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1. Materials and Methods  
Unless otherwise stated, reactions were performed under a nitrogen atmosphere using freshly 
dried solvents. Tetrahydrofuran (THF), methylene chloride (CH2Cl2), diethyl ether (Et2O), and 
toluene (PhMe) were dried by passing through activated alumina columns. Trimethylsilyl 
chloride (TMSCl) was distilled over calcium hydride. Trimethylsilyl bromide (TMSBr) and 
anhydrous dimethylacetamide (DMA) were purchased from Aldrich and stored in the glovebox. 
Manganese powder (–325 mesh, 99.3%) was purchased from Alfa Aesar. Zinc dust (97.5%) and 
nickel(II) chloride (NiCl2) were purchased from Strem. Tetrakis(dimethylamino)ethylene 
(TDAE) was purchased from TCI and stored in the glovebox. Unless otherwise stated, chemicals 
were used as received. All reactions were monitored by thin-layer chromatography (TLC) using 
EMD/Merck silica gel 60 F254 pre-coated plates (0.25 mm) and were visualized by ultraviolet 
(UV) light or with cerium ammonium molybdate (CAM) staining. Flash column chromatography 
was performed as described by Still et al.1 using silica gel (230-400 mesh) purchased from 
Silicycle or 10% AgNO3 doped silica gel (+230 mesh) purchased from Sigma Aldrich. Optical 
rotations were measured on a Jasco P-2000 polarimeter using a 100 mm path-length cell at 589 
nm. 1H and 13C NMR spectra were recorded on a Bruker Avance III HD with Prodigy cyroprobe 
(at 400 MHz and 101 MHz, respectively), a Varian 400 MR (at 400 MHz and 101 MHz, 
respectively), or a Varian Inova 500 (at 500 MHz and 126 MHz, respectively). 1H and 19F NMR 
spectra were also recorded on a Varian Inova 300 (at 300 MHz and 282 MHz, respectively). 
NMR data is reported relative to internal CHCl3 (1H, δ = 7.26), CDCl3 (13C, δ = 77.1), C6F6 (19F, 
δ = -164.9), CH3C6D5 (1H, δ = 2.09), and CD3C6D5 (13C, δ = 20.4). Data for 1H NMR spectra are 
reported as follows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), integration). 
Multiplicity and qualifier abbreviations are as follows: s = singlet, d = doublet, t = triplet, q = 
quartet, m = multiplet. IR spectra were recorded on a Perkin Elmer Paragon 1000 spectrometer 
and are reported in frequency of absorption (cm–1). Analytical chiral SFC was performed with a 
Mettler SFC supercritical CO2 chromatography system with Chiralcel AD-H, OD-H, AS-H, OB-
H, and OJ-H columns (4.6 mm x 25 cm). LRMS were obtained using an Aglient 1290 
Infinity/6140 Quadrupole system (LC-MS) or an Agilent 7890A GC/5975C VL MSD system 
(GC-MS). HRMS were acquired from the Caltech Mass Spectral Facility using fast-atom 
bombardment (FAB), electrospray ionization (ESI-TOF), or electron impact (EI). X-ray 
diffraction and elemental analysis (EA) were performed at the Caltech X-ray Crystal Facility. 
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Commonly Used Abbreviations: 
ee – enantiomeric excess; EA – elemental analysis; Et2O – diethyl ether; EtOAc – ethyl acetate; 
FTIR – Fourier transform infrared; HRMS – high-resolution mass spectrometry; IPA – 
isopropanol; LRMS – low-resolution mass spectrometry; m.p. – melting point; NHP – N-
hydroxyphthalimide; NMR – nuclear magnetic resonance; Rf – retention factor; SFC – 
supercritical fluid chromatography; TDAE – tetrakis(dimethylamino)ethylene 
 
2. Nickel(II) Complex Preparation 
Bis((3aR,8aS)-3a,8a-dihydro-8H-indeno[1,2-d]oxazol-2-yl)methane (S1) 
 
According to a procedure by Snyder and coworkers,2 the (1R,2S)-(+)-cis-1-amino-2-indanol 
(4.70 g, 31.5 mmol, 2.1 equiv) and diethyl malonimidate dihydrochloride (3.47 g, 15 mmol, 
1 equiv) were added to a flame-dried 1 L round bottom flask fitted with a reflux condenser and a 
magnetic stir bar, and put under an inert atmosphere (N2). Then CH2Cl2 (360 mL) was added and 
the solution was heated at 45 °C for 18 hours. The reaction was cooled, then quenched with 
water (690 mL). The layers were separated, the aqueous layer was extracted with CH2Cl2 (4 x 
180 mL), and the combined organic layers were dried with MgSO4, filtered, and concentrated. 
The crude material was purified by recrystallization from cooling hot ethanol to yield 3.30 g 
(67% yield) of S1 as a white solid. Spectral data matched those reported in literature.2 
 
(3aR,3a’R,8aS,8a’S)-2,2’-(Cyclopropane-1,1-diyl)bis(3a,8a-dihydro-8H-indeno[1,2-d]-
oxazole) (L) 
 
According to a procedure by Sibi and coworkers,3 the bis(oxazoline) ligand S1 (1.65 g, 5 mmol, 
1 equiv) was added to a flame-dried 200 mL round bottom flask with a magnetic stir bar and put 
under an inert atmosphere (N2). The compound was dissolved in THF (25 mL) and cooled to 
0 °C before dry sodium hydride (60 wt% in mineral oil, 601 mg, 15 mmol, 3 equiv) was added in 
 reflux, 18 h
O
N N
ONH2
OH EtO OEt
NH NH
2 HCl CH2Cl2
O
N N
O O
N N
O
THF, 50 °C, 2 h
NaH
1,2-dibromoethane
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portions. Note: Wet NaH resulted in saponification of the oxazoline, which could be removed by 
column chromatography (silica, 10% MeOH/CH2Cl2). The solution was allowed to stir for 30 
minutes before 1,2-dibromoethane (517 µL, mmol, 1.2 equiv) was added dropwise over the 
course of 10 minutes. The reaction was warmed to 50 °C and stirred for 2 hours. Note: Aliquots 
could be monitored by 1H NMR to ensure complete conversion of the starting material. The 
reaction was quenched with aqueous NH4Cl (25 mL) and extracted with CH2Cl2 (2 x 85 mL). 
The combined organic layers were dried with Na2SO4, filtered, and concentrated under reduced 
pressure. The crude material was purified by recrystallization from cooling hot ethanol to yield 
1.46 g (82% yield) of L as a light tan solid. Spectral data matched those reported in literature.3 
 
Nickel(II) bis(bromide) (3aR,3a’R,8aS,8a’S)-2,2’-(cyclopropane-1,1-diyl)bis(3a,8a-dihydro-
8H-indeno[1,2-d]oxazole) (4b) 
 
Similar to a procedure reported by Evans and coworkers,4 the bis(oxazoline) ligand L (1.07 g, 
3.0 mmol, 1 equiv) and anhydrous nickel(II) bromide (655 mg, 3.0 mmol, 1 equiv) were added to 
a round bottom flask equipped with a magnetic stir bar and dissolved in a mixture of acetonitrile 
(CH3CN, 65 mL) and water (0.75 mL). The solution was heated to 80 °C for 6 hours to afford a 
dark purple solution. The reaction was concentrated under reduced pressure and the obtained 
solid was saturated in CH2Cl2, filtered through a plug of cotton, dispensed into four 
20 mL scintillation vials, and recrystallized by vapor diffusion (CH2Cl2/pentane) to afford dark 
purple crystals suitable for X-ray diffraction. For the isolation of 4b, the crystals were washed 
with hexane, which was added by pipet and subsequently removed. The crystals were removed 
with a spatula, transferred to a new vial, and crushed to provide a powder. The resulting complex 
was dried under vacuum to yield 1.6 g (91% yield) of 4b as a purple solid. 
m.p. = >300 °C 
1H NMR (400 MHz, CDCl3): δ 96.48 (s, 2H), 46.46 (s, 2H), 20.16 (d, J = 17.1 Hz, 2H), 11.67 – 
10.85 (m, 6H), 10.55 (d, J = 16.6 Hz, 2H), 6.96 (s, 2H), 5.40 (s, 2H), -0.65 (s, 2H). 
FTIR (NaCl, thin film, cm-1): 3333, 2222, 1660, 1479, 1461, 1444, 1427, 1312, 1247, 1227, 
1214, 1120, 1010, 911, 859, 758, 728. 
CH3CN/H2O
80 °C, 6 h
NiBr2
O
N N
O
Ni
BrBr
O
N N
O
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EA: Anal. Calc’d. for 4b, C23H20Br2N2NiO2 (%): C, 48.05; H, 3.51; N, 4.87. Found: C, 48.38; 
H, 3.54; N, 4.84. 
 
 
(Left) Crystallized 4b following vapor diffusion. (Center) Large crystals of 4b. (Right) The powdered 
form of 4b after crushing the crystals with a spatula and drying under vacuum. 
 
X-Ray Structure Determination 
Low-temperature diffraction data (φ- and ω-scans) were collected on a Bruker AXS KAPPA 
APEXII diffractometer coupled to a CCD detector with Mo-Kα radiation (λ = 0.71073 Å) from a 
fine-focus sealed X-ray tube. All diffractometer manipulations, including data collection 
integration, and scaling were carried out using the Bruker APEXII software.5 Absorption 
corrections were applied using SADABS.6 The structure was solved by intrinsic phasing using 
SHELXT7 and refined against F2 on all data by full-matrix least squares with SHELXL-20147 
using established refinement techniques.8 All non-hydrogen atoms were refined anisotropically. 
All hydrogen atoms were included into the model at geometrically calculated positions and 
refined using a riding model. Compound 4b crystallizes in the tetragonal space group P41 with 
one molecule in the asymmetric unit. The structure was solved as a merohedral twin with 
rotation around an axis 45° between a and b. The twin law was defined as the matrix (0.0, 1.0, 
0.0, 1.0, 0.0, 0.0, 0.0, 0.0, -1.0). The BASF parameter [0.4980(14)] gave the twin ratio as 
0.50:0.50. Absolute configuration was determined by anomalous dispersion (Flack = 0.011(2)).9 
Crystallographic data for 4b can be obtained free of charge from The Cambridge 
Crystallographic Data Centre (CCDC) via www.ccdc.cam.ac.uk/data_request/cif under CCDC 
deposition number 1501744. Graphical representation of the structure with 50% probability 
thermal ellipsoids was generated using Mercury visualization software. 
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Table S1.  Crystal data and structure refinement for 4b. 
Identification code  JLH-3-168 
Empirical formula  C23H20Br2N2NiO2 
Formula weight  574.94 
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  Tetragonal 
Space group  P41 
Unit cell dimensions a = 9.4823(6) Å α= 90°. 
 b = 9.4823(6) Å β= 90°. 
 c = 24.418(2) Å γ = 90°. 
Volume 2195.5(3) Å3 
Z 4 
Density (calculated) 1.739 Mg/m3 
Absorption coefficient 4.546 mm-1 
F(000) 1144 
Crystal size 0.31 x 0.27 x 0.14 mm3 
Theta range for data collection 0.834 to 38.918°. 
Index ranges -16<=h<=16, -16<=k<=16, -42<=l<=43 
Reflections collected 113308 
Independent reflections 12464 [R(int) = 0.0431] 
Completeness to theta = 25.242° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7476 and 0.5466 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 12464 / 1 / 272 
Goodness-of-fit on F2 1.056 
Final R indices [I>2sigma(I)] R1 = 0.0470, wR2 = 0.1114 
R indices (all data) R1 = 0.0580, wR2 = 0.1168 
Absolute structure parameter 0.011(2) 
Extinction coefficient n/a 
Largest diff. peak and hole 2.381 and -1.019 e.Å-3 
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3. Large Scale Preparation of TDAE 
 
N,N,N’,N’-tetramethylformamidinium chloride (S2) 
 
According to a procedure by Bestmann and coworkers,10 the dimethylcarbamyl chloride (500 
mmol, 46 mL, 1 equiv) and anhydrous dimethylformamide (DMF, 1 mol, 77 mL, 2 equiv) were 
added under an inert atmosphere (N2) to a flame-dried 500 mL round bottom flask fitted with a 
reflux condenser and a magnetic stir bar. The solution was heated to 120 °C for 3 days, during 
which the reaction remained a homogeneous solution and turned dark brown in color. The 
reaction was removed from the stir plate and allowed to cool to room temperature, which 
initiated crystallization of the formamidinium chloride salt. Anhydrous diethyl ether (200 mL) 
was added to the crude reaction, swirled vigorously, quickly transferred to a fritted glass funnel, 
and filtered under a cone of argon gas. The crystals were quickly transferred to a round bottom 
flask and dried overnight under vacuum to yield 60.3 g (88% yield) of N,N,N’,N’ tetramethyl-
formamidinium chloride as a tan solid. The product is extremely hygroscopic, thus it was stored 
in the glovebox away from ambient moisture. 
 
   
(Left) Reaction after heating for 3 days. (Center) Precipitated salt after cooling the reaction flask. 
(Right) Filtering the salt under a flow of argon. 
Me
N
Me
N
Me
Me
Cl
120 °C, 3 d
O
HN
Me
Me
O
ClN
Me
Me
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(Left) Drying the salt under vacuum. (Right) Dried formamidinium salt stored in the glovebox. 
 
Tris(dimethylamino)methane (S3) 
 
Similar to a procedure by Wasserman and coworkers,11 anhydrous diethyl ether (500 mL) and 
dimethylamine (440 mL, 2 M in THF, 369 mmol, 2 equiv) were added under an inert atmosphere 
(N2) to a flame-dried 2 L round bottom flask with a magnetic stir bar. The reaction was cooled to 
–78 °C and n-butyllithium (n-BuLi, 210 mL, 2.5 M in hexane, 295 mmol, 1.2 equiv) was added 
via cannula under a stream of N2, resulting in a pink homogenous solution. The reaction was 
warmed to room temperature and stirred for 30 min, forming a white slurry. The flask was 
cooled to 0 °C, the N,N,N’,N’-tetramethylformamidinium chloride (60.3 g, 246 mmol, 1 equiv) 
was quickly added, and the reaction was warmed to room temperature and stirred overnight for 
8 h forming a light brown slurry. The flask was fitted with a distillation head and reflux 
condenser, and the solvent was distilled off into a 2 L receiving flask under ambient pressure. 
The flask was cooled and a new collection flask was added along with a vacuum regulator. The 
desired product was distilled out of the crude residue by slowly decreasing the pressure of the 
vacuum regulator to 1 mm Hg while increasing the oil bath temperature upwards of 100 °C. The 
liquid collected in the trap was THF, whereas the liquid collected in the receiving flask yielded 
45.2 g (71% yield) of tris(dimethylamino)methane as a colorless oil. 1H NMR (300 MHz, 
CDCl3): δ 3.02 (s, 1H), 2.29 (s, 18H). 13C NMR (101 MHz, CDCl3): δ 100.3, 41.3. 
Me
N
Me
N
Me
Me
Cl
0 °C to rt, 8 h
Me2NH, n-BuLi NMe2
NMe2Me2N
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(Left) Dimethylamine in THF added to 500 mL of diethyl ether. (Center) Reaction flask cooled to  
–78 °C and n-butyllithium solution added via cannula. (Right) Warming the reaction to room 
temperature forms a white slurry. 
 
    
(Left) Formamidinium chloride added to lithium dimethylamide at 0 °C, followed by warming to room 
temperature. (Center) Fractional distillation to remove solvent. (Right) Vacuum distillation to afford 
tris(dimethylamino)methane; an ice bath is used to cool the receiving flask. 
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Tetrakis(dimethylamino)ethylene (S4) 
 
Similar to a procedure by Murphy and coworkers,12 the tris(dimethylamino)methane was added 
to a 250 mL flame-dried round bottom flask fitted with a reflux condenser and a magnetic stir 
bar, and sparged with argon for 15 minutes. The reaction was heated to reflux for 5 days at
180 °C while being maintained under a steady stream of dry argon. The reaction was cooled to 
room temperature and remained under an argon atmosphere while the flask was fitted with a 
distillation apparatus (also under an argon atmosphere). The product was purified via fractional 
distillation under reduced pressure with the aid of a Vigreux column. The remaining 
tris(dimethylamino)methane starting material was collected in the first fraction at 1 mm Hg and 
30 °C as a colorless oil. When a yellow-green oil began to collect in the receiving flask, the 
fractions were exchanged and the desired product was collected at 1 mm Hg and 65 °C to yield 
19.4 g (62% yield) of tetrakis(dimethylamino)ethylene as a yellow-green oil. Spectra matched 
those reported in literature12 and also matched a sample of the commercially available material. 
The reagent was stored under inert atmosphere (N2) in the glovebox. 1H NMR (400 MHz, 
C6D5CD3): δ 2.57 (s, 24H). 13C NMR (101 MHz, C6D5CD3): δ 131.5, 41.2. 
 
   
(Left) Reaction heated to 180 °C. (Center) Reaction after 5 days at 180 °C. (Right) Fractional vacuum 
distillation to afford tetrakis(dimethylamino)ethylene. 
NMe2
NMe2Me2N 180 °C, 5 d
NMe2
NMe2Me2N
Me2N
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4. Optimization of Reaction Parameters (Table 1) 
On a bench-top to a 1 dram vial equipped with a stir bar was added vinyl bromide 1a (43 mg, 0.2 
mmol, 1 equiv), NHP ester 2 (59 mg, 0.2 mmol, 1 equiv), 4a or 4b (0.00–0.02 mmol, 0.00–0.10 
equiv), reductant (if Mn or Zn, 0.6 mmol, 3 equiv), and sodium iodide (0.0–15.0 mg, 0.0–0.1 
mmol, 0.0–0.5 equiv). Under an inert atmosphere in a glovebox, the vial was charged with DMA 
(0.2 mL, 1.0 M), the reagents were stirred until dissolved, and then cooled to the desired 
temperature. The reductant was then added (if tetrakis(dimethylamino)ethylene, TDAE, 0.3–0.6 
mmol, 70–140 µl, 1.5–3 equiv). The reaction was stirred for 10 minutes before the trimethylsilyl 
chloride (TMSCl) or trimethylsilyl bromide (TMSBr) was added (0.0–0.2 mmol, 0–1 equiv). The 
vial was sealed with a screw cap and stirred for 16 hours. As the reaction proceeds, the TDAE 
salts begin to precipitate, forming an orange slurry. The vial was removed from the glovebox and 
dibenzyl ether was added as an internal standard. The solution was quenched with aqueous HCl, 
extracted with Et2O, dried with MgSO4, and concentrated to afford the crude reaction mixture, 
which was analyzed by 1H NMR and chiral phase SFC to provide the reaction yield and 
enantioselectivity of the desired product. 
 
Table S2. Other Optimization Controls 
 
 
 
PMP
Br +
PMP
Me
Ph
NHP
O
Ph
Me
4b (10 mol %)
TDAE (1.5 equiv)
NaI (0.5 equiv)
TMSBr (1.0 equiv)
DMA, –7 °C, 16 h1a 2 3a
Entry yield (%)b ee (%)c
1
no NaI
no TDAE
no L·NiBr2 (4b)
TMSCl instead of TMSBr
2
3
4
MeCN instead of DMA
propylene carbonate instead of DMA
5
7
Deviation from Standard Conditionsa
68
0
0
67
30
43
95
--
--
95
99
95
--- 80 96
8
+ 50 mol % BHTd 80 969
NiBr2·diglyme and dtbbpy instead of 4b 59 --11
+ 50 mol % DHAe 73 9510
aReactions conducted on 0.2 mmol scale under N2 with 1.0 equiv of each electrophile. 
bDetermined by 1H NMR versus an internal standard. cDetermined by SFC using a chiral 
stationary phase. d3,5-di-tert-butyl-4-hydroxytoluene. e9,10-dihydroanthracene. PMP = 
para-methoxyphenyl
0.2 M instead of 1.0 M6 82 96
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5. Substrate Preparation (Note: These conditions are not fully optimized.) 
a. General Procedure 1: NHP Ester Synthesis 
 
To a round bottom flask equipped with a magnetic stir bar was added the carboxylic acid (1.0 
equiv), N-hydroxyphthalimide (1.0 equiv), and 4-dimethylaminopyridine (DMAP, 0.10 equiv). 
The reagents were dissolved in CH2Cl2 (0.2 M) and the N-(3-dimethylaminopropyl)-N-
ethylcarbodiimide (EDC, 1.1 equiv) was added. The reaction continued to stir overnight at room 
temperature. The crude reaction was concentrated to afford a thick oil, which was purified by 
column chromatography (silica, EtOAc/hexane or CH2Cl2) to afford the desired product.  
 
1,3-dioxoisoindolin-2-yl 2-phenylpropanoate (2) 
Prepared from 2-phenylpropanoic acid (5.0 g, 33.3 mmol) according to 
General Procedure 1. The crude residue was purified by filtering 
through a plug of silica with CH2Cl2 as the eluent to yield 8.7 g (88% 
yield) of 2 as a white solid. 
Rf = 0.28 (silica gel, 20% EtOAc/hexane, UV). 
m.p. = 62–64 °C 
1H NMR (400 MHz, CDCl3): δ 7.85 (d, J = 5.5, 3.1 Hz, 2H), 7.76 (dd, J = 5.5, 3.1 Hz, 2H), 
7.43 – 7.37 (m, 4H), 7.37 – 7.30 (m, 1H), 4.13 (q, J = 7.2 Hz, 1H), 1.68 (d, J = 7.2 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ 170.9, 161.9, 138.5, 134.9, 129.02, 128.98, 127.9, 127.7, 124.0, 
43.1, 19.1. 
FTIR (NaCl, thin film, cm-1): 1810, 1785, 1743, 1466, 1453, 1358, 1186, 1123, 1043, 1028, 
877, 695. 
HRMS (ESI-TOF, m/z): calc’d for C17H13NO4 [M+H]+: 296.0923; found: 296.0903. 
 
1,3-dioxoisoindolin-2-yl 2-(4-methoxyphenyl)propanoate (6a) 
Prepared from 2-(4-methoxyphenyl)propanoic acid (500 mg, 2.77 
mmol) according to General Procedure 1. The crude residue was 
purified by filtering through a plug of silica with 30% 
R2
N-hydroxyphthalimide
EDC, DMAP
CH2Cl2, rt
R2
R1 R1
O
O
N
O
OO
OH
Me
O
O
N
O
O
Me
O
O
N
O
OMeO
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EtOAc/hexane as the eluent to yield 671 mg (74% yield) of 6a as a white solid. 
Rf = 0.22 (silica gel, 20% EtOAc/hexane, UV). 
m.p. = 91–92 °C 
1H NMR (400 MHz, CDCl3): δ 7.86 (dd, J = 5.5, 3.1 Hz, 2H), 7.77 (dd, 2H), 7.33 (d, J = 8.7 
Hz, 2H), 6.92 (d, J = 8.8 Hz, 2H), 4.08 (q, J = 7.2 Hz, 1H), 3.81 (s, 3H), 1.65 (d, J = 7.2 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ 171.1, 162.0, 159.2, 134.9, 130.5, 129.0, 128.8, 124.0, 114.4, 
55.4, 42.2, 19.2. 
FTIR (NaCl, thin film, cm-1): 1810, 1784, 1743, 1611, 1513, 1467, 1371, 1249, 1185, 1123, 
1045, 1033, 878, 832, 696. 
HRMS (ESI-TOF, m/z): calc’d for C18H15NO5 [M+H]+: 326.1028; found: 326.1022. 
 
1,3-dioxoisoindolin-2-yl 2-(4-(trifluoromethyl)phenyl)propanoate (6b) 
Prepared from 2-(4-(trifluoromethyl)phenyl)propanoic acid (200 
mg, 0.92 mmol) according to General Procedure 1. The crude 
residue was purified by filtering through a plug of silica with 30% 
EtOAc/hexane as the eluent to yield 290 mg (87% yield) of 6b as a yellow solid. 
Rf = 0.28 (silica gel, 20% EtOAc/hexane, UV). 
m.p. = 76–77 °C 
1H NMR (400 MHz, CDCl3): δ 7.87 (dd, J = 5.6, 3.2 Hz, 2H), 7.78 (dd, J = 5.5, 3.1 Hz, 2H), 
7.66 (d, J = 7.8 Hz, 2H), 7.54 (d, J = 8.1 Hz, 2H), 4.19 (q, J = 7.2 Hz, 1H), 1.69 (d, J = 7.2 Hz, 
3H). 
13C NMR (101 MHz, CDCl3): δ 170.3, 161.9, 142.4 (q, JC-F = 1 Hz), 135.0, 130.2 (q, JC-F = 33 
Hz), 128.9, 128.2, 126.1 (q, JC-F = 4 Hz). 124.14, 124.11 (q, JC-F = 272 Hz), 43.0, 19.1. 
19F NMR (282 MHz, CDCl3): δ -65.8. 
FTIR (NaCl, thin film, cm-1): 1813, 1788, 1746, 1620, 1468, 1421, 1359, 1326, 1186, 1168, 
1125, 1079, 1067, 1048, 1017, 878, 842, 697. 
HRMS (ESI-TOF, m/z): calc’d for C18H12F3NO4 [M+H]+: 364.0797; found: 364.0815. 
 
  
Me
O
O
N
O
OF3C
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1,3-dioxoisoindolin-2-yl 2-(4-bromophenyl)propanoate (6c) 
Prepared from 2-(4-bromophenyl)propanoic acid (1.0 g, 4.65 mmol) 
according to General Procedure 1. The crude residue was purified 
by filtering through a plug of silica with 20% EtOAc/hexane as the 
eluent to yield 511 mg (48% yield) of 6c as a light yellow solid. 
Rf = 0.69 (silica gel, 20% EtOAc/hexane, UV). 
m.p. = 77–78 °C 
1H NMR (400 MHz, CDCl3): δ 7.86 (dd, J = 5.5, 3.0 Hz, 2H), 7.80 – 7.75 (m, 2H), 7.52 (d, J = 
8.5 Hz, 2H), 7.29 (d, J = 8.4 Hz, 2H), 4.08 (q, J = 7.2 Hz, 1H), 1.65 (d, J = 7.2 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ 170.5, 161.9, 137.4, 134.9, 132.2, 129.4, 129.0, 124.1, 122.0, 
42.6, 19.0. 
FTIR (NaCl, thin film, cm-1): 1811, 1786, 1742, 1489, 1467, 1369, 1186, 1133, 1078, 1046, 
1010, 877, 696. 
LRMS (API-ES, m/z): calc’d for C17H12BrNO4 [M+H2O]+: 391.0; found: 391.0. 
 
1,3-dioxoisoindolin-2-yl 2-(4-fluorophenyl)propanoate (6d) 
Prepared from 2-(4-fluorophenyl)propanoic acid (500 mg, 2.92 
mmol) according to General Procedure 1. The crude residue was 
purified by filtering through a plug of silica with 20% EtOAc/hexane 
as the eluent to yield 590 mg (63% yield) of 6d as a white solid. 
Rf = 0.35 (silica gel, 20% EtOAc/hexane, UV). 
m.p. = 108–110 °C 
1H NMR (400 MHz, CDCl3): δ 7.86 (dd, J = 5.6, 3.1 Hz, 2H), 7.77 (dd, J = 5.5, 3.1 Hz, 2H), 
7.41 – 7.35 (m, 2H), 7.12 – 7.05 (m, 2H), 4.11 (q, J = 7.2 Hz, 1H), 1.66 (d, J = 7.2 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ 170.78, 162.42 (d, JC-F = 246.4 Hz), 161.9, 134.9, 134.2 (d, JC-F 
= 3.3 Hz), 129.37 (d, JC-F = 8.3 Hz), 129.9, 124.1, 115.95 (d, JC-F = 21.5 Hz), 42.3, 19.2. 
19F NMR (282 MHz, CDCl3): δ -117.64 (tt, JF-H = 8.4, 5.2 Hz). 
FTIR (NaCl, thin film, cm-1): 1811, 1785, 1739, 1605, 1509, 1467, 1360, 1225, 1186, 1120, 
1045, 1016, 959, 877, 837, 783, 696. 
HRMS (FAB, m/z): calc’d for C17H12FNO4 [M+H]+: 314.0823; found: 314.0859. 
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1,3-dioxoisoindolin-2-yl 2-(4-(dimethylamino)phenyl)propanoate (6e) 
Prepared from 2-(4-(dimethylamino)phenyl)propanoic acid (392 
mg, 2.02 mmol) according to General Procedure 1, with the 
exception of no DMAP. The crude residue was purified column 
chromatography (silica, 20 to 50% EtOAc/hexane) to yield 640 mg (94% yield) of 6e as a yellow 
solid. 
Rf = 0.54 (silica gel, 50% EtOAc/hexane, UV). 
m.p. = 106–108 °C 
1H NMR (400 MHz, CDCl3): δ 7.85 (dd, J = 5.6, 3.1 Hz, 2H), 7.76 (dd, J = 5.5, 3.1 Hz, 2H), 
7.27 (d, J = 8.8 Hz, 2H), 6.75 (d, J = 8.8 Hz, 2H), 4.04 (q, J = 7.2 Hz, 1H), 2.95 (s, 6H), 1.64 (d, 
J = 7.2 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ 171.4, 162.1, 150.2, 134.8, 129.1, 128.3, 126.0, 124.0, 112.8, 
42.1, 40.6, 19.2. 
FTIR (NaCl, thin film, cm-1): 1809, 1784, 1743, 1615, 1523, 1467, 1356, 1186, 1134, 1081, 
1044, 878, 819, 697. 
HRMS (FAB, m/z): calc’d for C19H18N2O4 [M+·]+: 338.1267; found: 338.1272. 
 
1,3-dioxoisoindolin-2-yl 2-(3,4-dichlorophenyl)propanoate (6f) 
Prepared from 2-(3,4-dichlorophenyl)propanoic acid (231 mg, 1.05 
mmol) according to General Procedure 1, with the exception of no 
DMAP. The crude residue was purified by column chromatography 
(silica, 0 to 15% EtOAc/hexane) to yield 241 mg (63% yield) of 6f as a white solid. 
Rf = 0.35 (silica gel, 20% EtOAc/hexane, UV). 
m.p. = 103–105 °C 
1H NMR (400 MHz, CDCl3): δ 7.87 (dd, J = 5.5, 3.1 Hz, 2H), 7.79 (dd, J = 5.5, 3.1 Hz, 2H), 
7.52 (d, J = 2.2 Hz, 1H), 7.47 (d, J = 8.3 Hz, 1H), 7.26 (dd, J = 8.3, 2.2 Hz, 1H), 4.08 (q, J = 7.2 
Hz, 1H), 1.66 (d, J = 7.2 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ 170.1, 161.9, 138.4, 135.0, 133.1, 132.2, 131.0, 129.9, 128.9, 
127.1, 124.2, 42.3, 19.0. 
FTIR (NaCl, thin film, cm-1): 2341, 2359, 1785, 1743, 1426, 1186, 1135, 1049, 962, 878, 696. 
HRMS (FAB, m/z): calc’d for C17H11Cl2NO4 [M+H]+: 364.0143; found: 364.0131. 
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1,3-dioxoisoindolin-2-yl 2-phenylbutanoate (6g) 
Prepared from 2-phenylbutanoic acid (5.0 g, 30.5 mmol) according to 
General Procedure 1. The crude residue was purified by column 
chromatography (silica, 20% EtOAc/hexane) to yield 8.1 g (86% yield) 
of 6g as a white solid. 
Rf = 0.31 (silica gel, 20% EtOAc/hexane, UV). 
m.p. = 61–64 °C 
1H NMR (400 MHz, CDCl3): δ 7.85 (dd, J = 5.6, 3.1 Hz, 2H), 7.76 (dd, J = 5.5, 3.1 Hz, 2H), 
7.42 – 7.29 (m, 5H), 3.86 (t, J = 7.6 Hz, 1H), 2.31 – 2.18 (m, 1H), 2.03 – 1.90 (m, 1H), 1.04 (t, J 
= 7.4 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ 170.4, 162.0, 136.9, 134.8, 129.0, 128.9, 128.2, 128.0, 124.0, 
50.5, 27.3, 12.0. 
FTIR (NaCl, thin film, cm-1): 1811, 1786, 1744, 1467, 1455, 1360, 1186, 1128, 1080, 1058, 
969, 877, 656. 
HRMS (ESI-TOF, m/z): calc’d for C18H15NO4 [M+H]+: 310.1079; found: 310.1061. 
 
1,3-dioxoisoindolin-2-yl 2,3-diphenylpropanoate (6h) 
Prepared from 2,3-diphenylpropanoic acid (353 mg, 1.56 mmol) 
according to General Procedure 1. The crude residue was purified by 
column chromatography (silica, 20% EtOAc/hexane) to yield 542 mg 
(94% yield) of 6h as a white solid. 
Rf = 0.28 (silica gel, 20% EtOAc/hexane, UV). 
m.p. = 116–119 °C 
1H NMR (400 MHz, CDCl3): δ 7.85 (dd, J = 5.5, 3.0 Hz, 2H), 7.76 (dd, J = 5.5, 3.1 Hz, 2H), 
7.41 – 7.20 (m, 8H), 7.15 – 7.10 (m, 2H), 4.23 (t, J = 7.6 Hz, 1H), 3.56 (dd, J = 13.9, 7.5 Hz, 
1H), 3.19 (dd, J = 13.9, 7.8 Hz, 1H). 
13C NMR (101 MHz, CDCl3): δ 170.0, 161.8, 137.7, 136.4, 134.8, 129.2, 129.0, 128.9, 128.6, 
128.3, 128.1, 126.9, 124.0, 50.9, 39.9. 
FTIR (NaCl, thin film, cm-1): 3030, 1810, 1784, 1744, 1496, 1467, 1454, 1359, 1186, 1134, 
1080, 1068, 972, 877, 736, 695. 
HRMS (ESI-TOF, m/z): calc’d for C23H17NO4 [M+H]+: 372.1236; found: 372.1236. 
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1,3-dioxoisoindolin-2-yl 3-methyl-2-phenylbutanoate (6i) 
Prepared from 3-methyl-2-phenylbutanoic acid (300 mg, 1.68 mmol) 
according to General Procedure 1. The crude residue was purified by 
filtering through a plug of silica with 20% EtOAc/hexane as the eluent 
to yield 509 mg (93% yield) of 6i as a white solid. 
Rf = 0.34 (silica gel, 20% EtOAc/hexane, UV). 
m.p. = 77–81 °C 
1H NMR (400 MHz, CDCl3): δ 7.84 (dd, J = 5.6, 3.1 Hz, 2H), 7.76 (dd, J = 5.5, 3.1 Hz, 2H), 
7.42 – 7.29 (m, 5H), 3.58 (d, J = 10.0 Hz, 1H), 2.51 – 2.37 (m, 1H), 1.23 (d, J = 6.6 Hz, 3H), 
0.84 (d, J = 6.7 Hz, 3H). 
13C NMR (101 MHz, CDCl3): δ 170.2, 162.0, 136.1, 134.8, 129.0, 128.8, 128.7, 128.0, 124.0, 
56.7, 32.6, 21.3, 20.3. 
FTIR (NaCl, thin film, cm-1): 2966, 1811, 1786, 1745, 1468, 1455, 1375, 1311, 1186, 1132, 
1080, 1060, 974, 889, 877, 786, 745, 696. 
HRMS (ESI-TOF, m/z): calc’d for C19H17NO4 [M+H]+: 324.1236; found: 324.1227. 
 
1,3-dioxoisoindolin-2-yl 3-((tert-butyldimethylsilyl)oxy)-2-phenylpropanoate (6j) 
To a round bottom flask equipped with a stirring magnet was added 
tropic acid (830 mg, 5 mmol, 1 equiv), tert-butyldimethylsilyl chloride 
(1.1 g, 5.5 mmol, 1.1 equiv), dimethylaminopyridine (63 mg, 0.5 mmol, 
0.1 equiv), and imidazole (682 mg, 10 mmol, 2 equiv). The reagents were dissolved in 15 mL of 
CH2Cl2 and stirred overnight at room temperature. The reaction was quenched with aq. NH4Cl, 
extracted with Et2O, dried with MgSO4, filtered, and concentrated under reduced pressure to 
afford crude 3-((tert-butyldimethylsilyl)oxy)-2-phenylpropanoic acid. This crude material was 
used in the esterification step without purification, which was performed according to General 
Procedure 1. The crude residue was purified by column chromatography and dried under high 
vacuum (silica, 0 to 20% EtOAc/hexane) to yield 664 mg (31% yield) of 6j as a colorless oil. 
Rf = 0.38 (silica gel, 20% EtOAc/hexane, UV). 
1H NMR (400 MHz, CDCl3): δ 7.86 (dd, J = 5.6, 3.1 Hz, 2H), 7.77 (dd, J = 5.5, 3.1 Hz, 2H), 
7.43 – 7.31 (m, 5H), 4.28 – 4.18 (m, 2H), 3.93 (dd, J = 8.6, 4.4 Hz, 1H), 0.89 (s, 9H), 0.05 (s, 
3H), 0.03 (s, 3H). 
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13C NMR (101 MHz, CDCl3): δ 169.0, 161.8, 134.8, 134.1, 129.1, 129.0, 128.5, 128.3, 124.0, 
65.3, 52.2, 25.9, 18.4, -5.4, -5.6. 
FTIR (NaCl, thin film, cm-1): 2953, 2929, 2856, 1814, 1788, 1747, 1468, 1361, 1256, 1186, 
1113, 1049, 1023, 877, 836, 780, 696. 
HRMS (ESI-TOF, m/z): calc’d for C23H27NO5Si [M+H]+: 426.1737; found: 426.1708. 
 
1,3-dioxoisoindolin-2-yl 2-phenylpent-4-enoate (6k) 
Prepared from 2-phenylpent-4-enoic acid (240 mg, 1.36 mmol) 
according to General Procedure 1. The crude residue was purified by 
column chromatography (silica, 0 to 20% EtOAc/hexane) to yield 295 
mg (67% yield) of 6k as a white solid. 
Rf = 0.31 (silica gel, 20% EtOAc/hexane, UV). 
m.p. = 68–69 °C 
1H NMR (400 MHz, CDCl3): δ 7.85 (dd, J = 5.6, 3.1 Hz, 2H), 7.76 (dd, J = 5.5, 3.1 Hz, 2H), 
7.42 – 7.31 (m, 5H), 5.81 (ddt, J = 17.1, 10.2, 6.9 Hz, 1H), 5.16 (dq, J = 17.1, 1.5 Hz, 1H), 5.14 
– 5.09 (m, 1H), 4.04 (dd, J = 8.0, 7.2 Hz, 1H), 3.00 – 2.90 (m, 1H), 2.68 (dtt, J = 14.3, 7.1, 1.3 
Hz, 1H). 
13C NMR (101 MHz, CDCl3): δ 169.9, 161.9, 136.4, 134.9, 134.0, 129.02, 128.99, 128.2, 128.1, 
124.0, 118.3, 48.8, 37.9. 
FTIR (NaCl, thin film, cm-1): 1811, 1785, 1743, 1467, 1359, 1186, 1133, 1080, 1068, 971, 877, 
695. 
HRMS (ESI-TOF, m/z): calc’d for C19H15NO4 [M+H]+: 322.1079; found: 322.1063. 
 
1,3-dioxoisoindolin-2-yl 5-chloro-2-phenylpentanoate (6l) 
Prepared from 5-chloro-2-phenylpentanoic acid (1.01 g, 4.75 mmol) 
according to General Procedure 1. The crude residue was purified by 
filtering through a plug of silica with 20% EtOAc/hexane as the eluent 
to yield 977 mg (58% yield) of 6l as a white solid. 
Rf = 0.25 (silica gel, 20% EtOAc/hexane, UV). 
m.p. = 96–99 °C 
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1H NMR (400 MHz, CDCl3): δ 7.85 (dd, J = 5.6, 3.1 Hz, 2H), 7.77 (dd, J = 5.5, 3.1 Hz, 2H), 
7.42 – 7.31 (m, 5H), 3.97 (t, J = 7.7 Hz, 1H), 3.64 – 3.52 (m, 2H), 2.34 (dddd, J = 13.2, 10.4, 
8.0, 5.1 Hz, 1H), 2.13 (dddd, J = 13.5, 10.3, 7.4, 5.5 Hz, 1H), 2.01 – 1.78 (m, 2H). 
13C NMR (101 MHz, CDCl3): δ 170.1, 161.9, 136.4, 134.9, 129.1, 129.0, 128.2, 128.1, 124.1, 
48.2, 44.4, 31.2, 30.1. 
FTIR (NaCl, thin film, cm-1): 2960, 1811, 1786, 1744, 1494, 1455, 1468, 1361, 1186, 1134, 
1081, 1045, 965, 878, 697. 
HRMS (FAB, m/z): calc’d for C19H16NO4Cl [M+H]+: 358.0846; found: 358.0872. 
 
1,3-dioxoisoindolin-2-yl 2-methoxy-2-phenylacetate (8) 
Prepared from 2-methoxy-2-phenylacetic acid (830 mg, 5.0 mmol) 
according to General Procedure 1. The crude residue was purified by 
column chromatography (silica, 10 to 30% EtOAc/hexane) to yield 
1.16 g (74% yield) of 8 as a colorless oil. Note: This compound will slowly decompose 
(solidifies/hydrolyzes) under ambient conditions over extended periods (~1 month). 
Rf = 0.22 (silica gel, 20% EtOAc/hexane, UV). 
1H NMR (400 MHz, CDCl3): δ 7.83 (dd, J = 5.5, 3.1 Hz, 2H), 7.75 (dd, J = 5.5, 3.1 Hz, 2H), 
7.60 – 7.52 (m, 2H), 7.50 – 7.37 (m, 3H), 5.19 (s, 1H), 3.56 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 167.4, 161.6, 134.9, 134.4, 129.6, 129.0, 128.8, 127.6, 124.1, 
81.0, 58.0. 
FTIR (NaCl, thin film, cm-1): 1818, 1789, 1745, 1468, 1359, 1186, 1079, 988, 969, 877, 696. 
HRMS (ESI-TOF, m/z): calc’d for C17H13NO5 [M+H]+: 312.0872; found: 312.0846. 
 
1,3-dioxoisoindolin-2-yl 2-cyclopropyl-2-phenylacetate (10) 
Prepared from 2-cyclopropyl-2-phenylacetic acid (50 mg, 0.28 mmol) 
according to General Procedure 1. The crude residue was purified by 
filtering through a plug of silica with 20% EtOAc/hexane as the eluent 
to yield 80 mg (89% yield) of 10 as a white solid. 
Rf = 0.39 (silica gel, 50% EtOAc/hexane, UV). 
m.p. = 92–93 °C 
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1H NMR (400 MHz, CDCl3): δ 7.87 (dd, J = 5.5, 3.0 Hz, 2H), 7.81 – 7.75 (m, 2H), 7.50 – 7.45 
(m, 2H), 7.44 – 7.38 (m, 2H), 7.37 – 7.31 (m, 1H), 3.29 (d, J = 9.7 Hz, 1H), 1.53 (dtt, J = 9.7, 
8.0, 4.9 Hz, 1H), 0.82 (dddd, J = 9.0, 8.1, 4.6, 2.9 Hz, 1H), 0.69 (dddd, J = 8.9, 8.0, 5.8, 4.8 Hz, 
1H), 0.63 – 0.55 (m, 1H), 0.42 – 0.34 (m, 1H). 
13C NMR (101 MHz, CDCl3): δ 170.0, 162.0, 136.8, 134.9, 129.1, 128.9, 128.1, 128.0, 124.1, 
53.4, 14.6, 4.91, 4.90. 
FTIR (NaCl, thin film, cm-1): 1811, 1742, 1362, 1170, 1135, 1063, 974, 876. 
HRMS (FAB, m/z): calc’d for C19H15NO4 [M+H]+: 322.1079; found: 322.1065. 
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b. Vinyl Bromide Synthesis 
Vinyl bromides 1a, 1b, 1c, 1j, and 1m were prepared according to procedures reported and 
referenced by Reisman and coworkers.13 
 
 
Vinyl bromides 1d, 1e, 1f, 1g, and 1i were prepared according to General Procedure 2. Vinyl 
bromides 1d and 1f were subjected to NaOH-mediated isomerization to afford geometrically 
pure E-isomer. Vinyl bromides 1e, 1g, and 1i were not subjected to NaOH-mediated 
isomerization; vinyl bromide 1e decomposes under these conditions therefore the substrate used 
in the cross-coupling reaction was a 93:7 E:Z ratio. The NMR spectra of 1d,13 1e,15 and 1f16 
matched those reported in literature. The characterization data for 1g and 1i are reported below. 
 
 
General Procedure 2: Vinyl Bromides from Aldehydes 
 
General Procedure 2, Part A: According to a procedure by Alexakis and coworkers,14 a flame 
dried round bottom flask equipped with a magnetic stir bar was put under an inert atmosphere 
(N2) and charged with the tetrabromomethane (20 mmol, 2 equiv) and triphenylphosphine (40 
mmol, 4 equiv). The flask was cooled to 0 °C and then CH2Cl2 (30 mL) was added, followed by 
the triethylamine (10 mmol, 1 equiv). The aldehyde (10 mmol, 1 equiv) was dissolved in CH2Cl2 
(5 mL) and added dropwise to the reaction mixture. The reaction was allowed to warm to room 
temperature and continued to stir for 90 minutes. The reaction was removed from the stir plate 
and slowly added to a vigorously stirring solution of Et2O (150 mL) and hexane (150 mL), 
filtered through a plug of silica gel, and concentrated under reduced pressure to afford the 
desired dibromoalkene. 
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4-(2,2-dibromovinyl)phenyl 4-methylbenzenesulfonate (S5) 
Prepared from 4-formylphenyl 4-methylbenzenesulfonate (5.14 g, 18.6 
mmol) following General Procedure 2A. The crude residue was purified by 
filtering through a plug of silica to yield 6.2 g (77% yield) of S5 as a white solid. 
Rf = 0.38 (silica gel, 10% EtOAc/hexane). 
m.p. = 108–110 °C 
1H NMR (400 MHz, CDCl3): δ 7.73 – 7.67 (m, 2H), 7.49 – 7.43 (m, 2H), 7.41 (s, 1H), 7.34 – 
7.29 (m, 2H), 7.01 – 6.95 (m, 2H), 2.45 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 149.3, 145.7, 135.6, 134.2, 132.3, 129.9, 129.8, 128.6, 122.5, 
90.8, 21.9. 
FTIR (NaCl, thin film, cm-1):  3081, 3065, 1929, 1910, 1596, 1500, 1495, 1406, 1379, 1360, 
1271, 1178, 1160, 1094, 1018, 877, 832, 914, 781, 732, 706, 698, 658. 
HRMS (FAB, m/z): calc’d for C15H12Br2O3S [M+H]+: 432.8932; found: 432.8915. 
 
5-(2,2-dibromovinyl)-2-methoxypyridine (S6) 
Prepared from 6-methoxynicotinaldehyde (1.36 g, 10 mmol) following 
General Procedure 2A. The crude residue was purified by column 
chromatography (silica, 1% Et2O/hexane to 10% Et2O/hexane) to yield 570 mg (20% yield) of 
S6 as a yellow oil. 
Rf = 0.48 (silica gel, 10% EtOAc/hexane). 
1H NMR (500 MHz, CDCl3): δ 8.25 (dt, J = 2.4, 0.6 Hz, 1H), 7.90 (ddd, J = 8.7, 2.5, 0.6 Hz, 
1H), 7.37 (q, J = 0.6 Hz, 1H), 6.74 (dt, J = 8.7, 0.5 Hz, 2H), 3.94 (s, 3H). 
13C NMR (126 MHz, CDCl3): δ 163.8, 147.6, 137.8, 133.5, 124.9, 110.7, 89.3, 53.8. 
FTIR (NaCl, thin film, cm-1): 2982, 2946, 1603 1595, 1561, 1491, 1381, 1309, 1289, 1254, 
1132, 1024, 1014, 867, 819, 751. 
HRMS (ESI-TOF, m/z): calc’d for C8H7NOBr2 [M+H]+: 291.8973; found: 291.8967. 
 
General Procedure 2, Part B: The dibromoalkene (1.7 mmol, 1 equiv) and diethyl phosphite 
(5.1 mmol, 3 equiv) were added to a vial with a magnetic stirring rod and put under an inert 
atmosphere (N2). The solution was cooled to 0 °C and the triethylamine (5.1 mmol, 3 equiv) was 
added dropwise. The reaction was warmed to room temperature and stirred overnight. The 
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reaction was quenched with water (5 mL) and extracted with CH2Cl2 (20 mL). The organic layer 
was washed with brine (5 mL), dried with Na2SO4, filtered, and concentrated under reduced 
pressure. The crude residue was purified by column chromatography (silica, ether/hexanes) to 
afford the vinyl bromide. 
 
(E)-4-(2-bromovinyl)phenyl 4-methylbenzenesulfonate (1g) 
 Prepared from S5 (4.32 g, 10 mmol) following General Procedure 2B. The 
crude residue was purified by column chromatography (silica, 5% 
EtOAc/hexane to 20% EtOAc/hexane) to yield 2.75 g (78% yield, 90:10 E:Z) of 1g as a white 
solid.  
Rf = 0.34 (silica gel, 10% EtOAc/hexane). 
m.p. = 90–93 °C 
1H NMR (400 MHz, CDCl3): δ 7.72 – 7.67 (m, 2H), 7.34 – 7.28 (m, 2H), 7.23 – 7.17 (m, 2H), 
7.03 (d, J = 14.0 Hz, 1H), 6.96 – 6.90 (m, 2H), 6.73 (d, J = 14.0 Hz, 1H), 2.44 (s, 3H). 
13C NMR (101 MHz, CDCl3): δ 149.3, 145.6, 135.9, 134.9, 132.3, 129.9, 128.6, 127.3, 122.9, 
107.7, 21.9. 
HRMS (FAB, m/z): calc’d for C15H13BrO3S [M+·]+: 353.9748; found: 353.9733. 
 
(E)-5-(2-bromovinyl)-2-methoxypyridine (1i) 
Prepared from S6 (500 mg, 1.7 mmol) following General Procedure 2B. The 
crude residue was purified by column chromatography (silica, 2% 
Et2O/hexane to 5% Et2O/hexane) to yield 314 mg (86% yield, 96:4 E:Z) of 1i as a white solid.  
Rf = 0.46 (silica gel, 10% EtOAc/hexane). 
m.p. = 53–56 °C 
1H NMR (500 MHz, CDCl3): δ 8.05 (d, J = 2.5 Hz, 1H), 7.54 (ddd, J = 8.7, 2.5, 0.4 Hz, 1H), 
7.02 (dq, J = 14.0, 0.5 Hz, 1H), 6.70 (dt, J = 8.7, 0.6 Hz, 1H), 6.65 (d, J = 14.0 Hz, 1H), 3.93 (s, 
3H). 
13C NMR (126 MHz, CDCl3): δ 164.0, 145.3, 135.3, 133.5, 125.5, 111.4, 105.5, 53.7. 
FTIR (NaCl, thin film, cm-1): 3061, 2943, 1613, 1598, 1562, 1490, 1385, 1303, 1285, 1258, 
1238, 1026, 1015, 947, 837, 790. 
HRMS (ESI-TOF, m/z): calc’d for C8H8NOBr [M+H]+: 213.9868; found: 213.9858. 
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Vinyl bromide 1h was prepared by a NaOH-mediated isomerization of commercially available 
β-bromostyrene as reported by Alexakis and coworkers.14  
 
 
Vinyl bromide 1k was prepared via a hydrozirconation/bromination sequence similar to a 
procedure reported by Zhou, Lin, and coworkers.17 The NMR spectra matched those reported in 
literature.18 
 
 
Vinyl bromide 1l was prepared according to a procedure reported by Wolfe and coworkers.19  
 
 
Vinyl bromides 1n and 1o were purchased from a commercial source (Sigma Aldrich). 
 
Br
1h
Br
1k
Cl
Br
1l
Me
1n
BO
O
NMe
O
O
Br
TMS
Br
1o
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6. Vinyl Bromide-NHP Ester Cross-Coupling 
 
a. General Procedure 3: Reaction on 0.2 mmol scale:  
On a bench-top, a 1 dram vial equipped with a stir bar was charged with the vinyl bromide (if air 
stable, 0.2 mmol, 1 equiv), NHP ester (0.2 mmol, 1 equiv), 4b (11.5 mg, 0.02 mmol, 0.10 equiv), 
and sodium iodide (15.0 mg, 0.1 mmol, 0.5 equiv). The vial was then brought into the glovebox 
and charged with the vinyl bromide (if air sensitive, 0.2 mmol, 1 equiv) and DMA (0.2 mL,
1.0 M). The vial was then cooled to –7 °C and the reagents were stirred at 250 rpm until 
dissolved. Note: The recirculating Julabo LH45 chiller was set to –10 °C however an external 
thermometer in the glovebox read the temperature as –7 °C. The tetrakis(dimethyl-
amino)ethylene (TDAE, 0.3 mmol, 70 µl, 1.5 equiv) was added and stirred for 10 minutes before 
the trimethylsilyl bromide (TMSBr, 0.2 mmol, 26 µL, 1 equiv) was added. The vial was sealed 
with a screw cap and stirred under nitrogen at –7 °C for 16 hours (overnight) in temperature 
controlled well plates in the glovebox. Note: Monitoring the reaction kinetics for product 3a 
revealed that the reaction went to >90% conversion after 1 hour, however we choose to run 
these reactions overnight to ensure full conversion. As the reaction proceeds, the TDAE salts 
begin to precipitate, forming an orange slurry. The crude reaction was quenched with 0.5 mL of 
1 M HCl, diluted with water (5 mL), and extracted with diethyl ether (3 x 10 mL). Note: In order 
to efficiently remove all of the viscous reaction contents from the vial, we found it useful to fill 
the vial ¾ full with an extraction solvent (2.5 mL each time: first HCl/water, then Et2O, water, 
Et2O 3x), screw on a Teflon cap, and shake the vial vigorously with the stir bar still inside. The 
contents could then be easily poured into a separatory funnel. The combined organic layers were 
washed with brine (5 mL), dried with MgSO4, filtered, and concentrated under reduced pressure. 
The crude residue was purified by column chromatography. 
 
  
R
Br
4b (10 mol %)
TDAE (1.5 equiv)
NaI (0.5 equiv)
TMSBr (1.0 equiv)
DMA, –7 °C, 16 h
R
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b. Assignment of Absolute Stereochemistry 
The absolute stereochemistry of 3a, 3b, and 3h were assigned by comparing the optical rotation 
of the purified products to literature values. The optical rotation of products 3a–d, 3j, 7a, 7c, 7d, 
7g, and 7h correspond with those in reported in literature synthesized using the same chiral 
ligand (R,R,S,S)-L.13 Chiral products 3e–g, 3i, 3k–o, 7b, 7e, 7f, 7i–l, and 9 were assigned by 
analogy. 
 
c. Images of Reaction Setup 
 
   
(Left) The computer console sets the chiller to –10.0 °C, while actual temperature reading is –7.1 °C; stir 
plate set at 250 rpm and reads 255.7 rpm. (Center) Reactions conducted on 0.2 mmol scale and stirred in 
the temperature controlled glovebox stir plates. (Right) Conducting the reaction on the benchtop on a 
5 mmol scale under a balloon of nitrogen; a cryocool is used to cool the reaction to –5 °C. 
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d. Characterization of Reaction Products 
  
(S,E)-1-methoxy-4-(3-phenylbut-1-en-1-yl)benzene (3a) 
Prepared from (E)-1-(2-bromovinyl)-4-methoxybenzene (1a, 43 mg, 0.2 
mmol) and 1,3-dioxoisoindolin-2-yl 2-phenylpropanoate (2, 59 mg, 0.2 
mmol) according to General Procedure 3. The crude residue was 
purified by column chromatography (silica gel, 10 to 20% toluene/hexane) to yield 3a (39 mg, 
80% yield) in 96% ee as a colorless oil. Spectral data matched those reported in literature.13 
 
Preparative Scale: Reaction on 5.0 mmol scale: 
On a bench-top to a 25 mL round bottom flask equipped with a stir bar was added vinyl bromide 
1a (1.065 g, 5 mmol, 1 equiv), NHP ester 2 (1.476 g, 5 mmol, 1 equiv), 4b (0.29 g, 0.5 mmol, 
0.10 equiv), and sodium iodide (0.37 g, 2.5 mmol, 0.5 equiv). The flask was sealed with a rubber 
septum, purged with nitrogen, and the reagents were dissolved in DMA (5.0 mL, 1.0 M). The 
flask was cooled to –5 °C by submerging it in an isopropanol bath cooled with a Thermo 
Scientific EK90 Immersion Cooler. Note: We found that TDAE will begin to freeze at 
temperatures lower than –8 °C with this setup. The tetrakis(dimethylamino)ethylene (TDAE, 
1.74 mL, 7.5 mmol, 1.5 equiv) was added and stirred for 10 minutes before the trimethylsilyl 
bromide (TMSBr, 0.66 mL, 5.0 mmol, 1 equiv) was added. The flask was stirred under a balloon 
of nitrogen at –5 °C for 16 hours. As the reaction proceeds, the TDAE salts begin to precipitate, 
forming an orange slurry. The crude reaction was quenched with 1 M HCl (30 mL), and 
extracted with diethyl ether (3 x 20 mL). The combined organic layers were washed with water 
(2 x 20 mL) and brine (20 mL), dried with MgSO4, filtered, and concentrated under reduced 
pressure. The crude residue was purified by column chromatography (silica gel, 10 to 20% 
toluene/hexane) to yield 3a (918 mg, 77% yield) in 91% ee as a colorless oil. 
 
Rf = 0.59 (silica gel, 10% EtOAc/hexane, UV). 
 
Chiral SFC: (OB-H, 2.5 mL/min, 20% IPA in CO2, λ = 254 nm): tR (major) = 7.1 min, 
tR (minor) = 8.4 min. 
 [𝒂]𝑫𝟐𝟓 = –34° (c = 1.0, CHCl3). 
 
MeO
Me
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1H NMR (400 MHz, CDCl3): δ 7.37 – 7.27 (m, 6H), 7.25 – 7.20 (m, 1H), 6.85 (d, J = 8.8 Hz, 
2H), 6.38 (d, J = 16.2 Hz, 1H), 6.27 (dd, J = 15.9, 6.7 Hz, 1H), 3.81 (s, 3H), 3.70 – 3.58 (m, 1H), 
1.48 (d, J = 7.0 Hz, 3H). 
 
13C NMR (101 MHz, CDCl3): δ 158.9, 146.0, 133.3, 130.5, 128.6, 128.0, 127.42, 127.36, 126.3, 
114.0, 55.4, 42.7, 21.5. 
The optical rotation of 3a generated in the presence of (R,R,S,S)-4b was measured as [𝒂]𝑫𝟐𝟓 = –34° 
(c = 1.0, CHCl3). Lit: [𝒂]𝑫𝟐𝟓 = –16° (c = 1.28, CHCl3, S enantiomer, 94% ee).21 Based on the 
literature precedent, we assign our product as the S enantiomer. 
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(S,E)-1-methyl-4-(3-phenylbut-1-en-1-yl)benzene (3b) 
Prepared from (E)-1-(2-bromovinyl)-4-methylbenzene (1b, 39 mg, 0.2 
mmol) and 1,3-dioxoisoindolin-2-yl 2-phenylpropanoate (2, 59 mg, 0.2 
mmol) according to General Procedure 3. The crude residue was purified 
by column chromatography (10% AgNO3 silica gel, 0 to 2% Et2O/hexane) to yield 3b (39 mg, 
88% yield) in 95% ee as a colorless oil. Spectral data matched those reported in literature.13 
 
Rf = 0.26 (silica gel, hexane, UV). 
 
Chiral SFC: (OJ-H, 2.5 mL/min, 7% IPA in CO2, λ = 254 nm): tR (minor) = 8.0 min, tR (major) 
= 10.0 min. 
 [𝒂]𝑫𝟐𝟓 = –41° (c = 1.0, CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.41 – 7.30 (m, 6H), 7.30 – 7.24 (m, 1H), 7.16 (d, J = 8.0 Hz, 
2H), 6.52 – 6.34 (m, 2H), 3.74 – 3.64 (m, 1H), 2.38 (s, 3H), 1.53 (d, J = 7.0 Hz, 3H). 
 
13C NMR (101 MHz, CDCl3): δ 145.9, 136.9, 134.9, 134.3, 129.3, 128.6, 128.5, 127.5, 126.3, 
126.2, 42.7, 21.5, 21.3. 
The optical rotation of 3b generated in the presence of (R,R,S,S)-4b was measured as [𝒂]𝑫𝟐𝟓 = –41° 
(c = 1.0, CHCl3). Lit: [𝒂]𝑫𝟐𝟓 = +38.4° (c = 0.98, CHCl3, R enantiomer, 91% ee).22  Based on the 
literature precedent, we assign our product as the S enantiomer.  
  
Me
Me
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(S,E)-N,N-dimethyl-4-(3-phenylbut-1-en-1-yl)aniline (3c) 
Prepared from (E)-4-(2-bromovinyl)-N,N-dimethylaniline (1c, 45 mg, 
0.2 mmol) and 1,3-dioxoisoindolin-2-yl 2-phenylpropanoate (2, 59 mg, 
0.2 mmol) according to General Procedure 3. The crude residue was 
purified by column chromatography (silica gel, 5% Et2O/hexane) to yield 3c (38 mg, 76% yield) 
in 97% ee as a white solid. Spectral data matched those reported in literature.13 
 
Rf = 0.21 (silica gel, 5% Et2O/hexane, UV). 
 
m.p. = 65–67 °C 
 
Chiral SFC: (OB-H, 2.5 mL/min, 35% IPA in CO2, λ = 254 nm): tR (major) = 6.0 min, 
tR (minor) = 9.0 min. 
 [𝒂]𝑫𝟐𝟓 = –56° (c = 1.0, CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.40 – 7.29 (m, 6H), 7.29 – 7.23 (m, 1H), 6.73 (d, J = 8.8 Hz, 
2H), 6.40 (d, J = 15.9 Hz, 1H), 6.24 (dd, J = 15.8, 6.8 Hz, 1H), 3.72 – 3.62 (m, 1H), 3.00 (s, 6H), 
1.51 (d, J = 7.0 Hz, 3H). 
 
13C NMR (101 MHz, CDCl3): δ 149.9, 146.4, 131.2, 128.5, 128.4, 127.5, 127.1, 126.4, 126.1, 
112.7, 42.7, 40.8, 21.6. 
 
  
Me2N
Me
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(S,E)-1-(3-phenylbut-1-en-1-yl)-4-(trifluoromethyl)benzene (3d) 
Prepared from (E)-1-(2-bromovinyl)-4-(trifluoromethyl)benzene (1d, 50 
mg, 0.2 mmol) and 1,3-dioxoisoindolin-2-yl 2-phenylpropanoate (2, 59 
mg, 0.2 mmol) according to General Procedure 3. The crude residue was 
purified by column chromatography (silica gel, hexane) to yield 3d (48 mg, 87% yield) in 93% 
ee as a colorless oil. Spectral data matched those reported in literature.13 
 
Rf = 0.32 (silica gel, hexane, UV). 
 
Chiral SFC: (OJ-H, 2.5 mL/min, 3% IPA in CO2, λ = 254 nm): tR (minor) = 6.3 min, tR (major) 
= 7.3 min. 
 [𝒂]𝑫𝟐𝟓 = –27° (c = 1.0, CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.56 (d, J = 8.6 Hz, 2H), 7.46 (d, J = 8.2 Hz, 2H), 7.40 – 7.33 
(m, 2H), 7.33 – 7.23 (m, 3H), 6.52 (dd, J = 15.9, 6.2 Hz, 1H), 6.45 (d, J = 16.0 Hz, 1H), 3.74 – 
3.64 (m, 1H), 1.51 (d, J = 7.0 Hz, 3H). 
 
13C NMR (101 MHz, CDCl3): δ 145.2, 141.2 (q, JC-F = 1 Hz), 138.1, 129.0 (q, JC-F = 32 Hz), 
128.7, 127.5, 127.4, 126.6, 126.4, 125.6 (q, JC-F = 4 Hz), 124.4 (q, JC-F = 272 Hz), 42.8, 21.2. 
 
19F NMR (282 MHz, CDCl3): δ -65.6. 
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(S,E)-4-(3-phenylbut-1-en-1-yl)benzonitrile (3e) 
Prepared from methyl (E)-4-(2-bromovinyl)benzonitrile (1e, 42 mg, 0.2 
mmol) and 1,3-dioxoisoindolin-2-yl 2-phenylpropanoate (2, 59 mg, 0.2 
mmol) according to General Procedure 3. The crude residue was 
purified by column chromatography (silica gel, 0 to 3% Et2O/hexane) to yield 3e (42 mg, 91% 
yield) in 94% ee as a colorless oil. 
 
Rf = 0.42 (silica gel, 10% EtOAc/hexane, UV). 
 
Chiral SFC: (OB-H, 2.5 mL/min, 10% IPA in CO2, λ = 254 nm): tR (minor) = 9.5 min, 
tR (major) = 10.1 min. 
 [𝒂]𝑫𝟐𝟓 = –51° (c = 1.0, CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.54 (d, J = 8.5 Hz, 2H), 7.40 (d, J = 8.3 Hz, 2H), 7.36 – 7.30 
(m, 2H), 7.28 – 7.19 (m, 3H), 6.52 (dd, J = 15.9, 6.7 Hz, 1H), 6.40 (d, J = 16.0 Hz, 1H), 3.72 – 
3.61 (m, 1H), 1.48 (d, J = 7.0 Hz, 3H). 
 
13C NMR (101 MHz, CDCl3): δ 144.7, 142.1, 139.5, 132.4, 128.7, 127.3, 127.2, 126.7, 126.6, 
119.2, 110.2, 42.8, 21.0. 
 
FTIR (NaCl, thin film, cm-1): 3027, 2967, 2872, 2225, 1646, 1604, 1504, 1493, 1452, 1412, 
1176, 1013, 970, 866, 819, 763, 701. 
 
HRMS (FAB, m/z): calc’d for C17H15N [M+H]+: 234.1283; found: 234.1265. 
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Methyl (S,E)-4-(3-phenylbut-1-en-1-yl)benzoate (3f) 
Prepared from methyl (E)-4-(2-bromovinyl)benzoate (1f, 48 mg, 0.2 
mmol) and 1,3-dioxoisoindolin-2-yl 2-phenylpropanoate (2, 59 mg, 
0.2 mmol) according to General Procedure 3. The crude residue was 
purified by column chromatography (silica gel, 5% Et2O/hexane) to yield 3f (46 mg, 87% yield) 
in 95% ee as a colorless oil. 
 
Rf = 0.19 (silica gel, 5% Et2O/hexane, UV). 
 
Chiral SFC: (OB-H, 2.5 mL/min, 20% IPA in CO2, λ = 254 nm): tR (minor) = 8.2 min, 
tR (major) = 11.6 min. 
 [𝒂]𝑫𝟐𝟓 = –44° (c = 1.0, CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.96 (d, J = 8.4 Hz, 2H), 7.41 (d, J = 8.3 Hz, 2H), 7.37 – 7.30 
(m, 2H), 7.30 – 7.20 (m, 3H), 6.53 (dd, J = 15.9, 6.5 Hz, 1H), 6.44 (d, J = 16.1 Hz, 1H), 3.91 (s, 
3H), 3.72 – 3.62 (m, 1H), 1.49 (d, J = 7.0 Hz, 3H). 
 
13C NMR (101 MHz, CDCl3): δ 167.1, 145.2, 142.2, 138.2, 130.0, 128.7, 128.6, 127.9, 127.4, 
126.5, 126.1, 52.2, 42.8, 21.2. 
 
FTIR (NaCl, thin film, cm-1): 3025, 2963, 1718, 1605, 1492, 1433, 1411, 1276, 1177, 1108, 
1015, 968, 759, 698. 
 
LRMS (GC-MS, m/z): calc’d for C18H18O2 [M]+: 266.1; found: 266.1. 
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(S,E)-4-(3-phenylbut-1-en-1-yl)phenyl 4-methylbenzenesulfonate (3g) 
Prepared from (E)-4-(2-bromovinyl)phenyl 4-methylbenzenesulfonate 
(1g, 71 mg, 0.2 mmol) and 1,3-dioxoisoindolin-2-yl 2-
phenylpropanoate (2, 89 mg, 0.3 mmol) according to General 
Procedure 3 with the exception that 1.5 equiv NHP ester was used instead of 1.0 equiv. Note: 
The addition of excess NHP ester ensured full consumption of the vinyl bromide, which we found 
to be inseparable from the product when it remained in the crude reaction. The crude residue 
was purified by column chromatography (silica gel, hexane to 5% Et2O/hexane) to yield 3g (61 
mg, 80% yield) in 94% ee as a colorless oil. 
 
Rf = 0.39 (silica gel, 10% EtOAc/hexane, UV). 
 
Chiral SFC: (OJ-H, 2.5 mL/min, 15% IPA in CO2, λ = 254 nm): tR (minor) = 12.2 min, 
tR (major) = 13.7 min. 
 [𝒂]𝑫𝟐𝟓 = –24° (c = 1.0, CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.70 (d, J = 8.4 Hz, 2H), 7.36 – 7.28 (m, 4H), 7.28 – 7.20 (m, 
5H), 6.90 (d, J = 8.7 Hz, 2H), 6.39 – 6.30 (m, 2H), 3.69 – 3.58 (m, 1H), 2.45 (s, 3H), 1.46 (d, J = 
7.0 Hz, 3H). 
 
13C NMR (101 MHz, CDCl3): δ 148.5, 145.4, 145.3, 136.7, 136.5, 132.4, 129.8, 128.6, 127.3, 
127.2, 126.4, 122.5, 42.7, 21.8, 21.2. 
 
FTIR (NaCl, thin film, cm-1): 3061, 3028, 2966, 2928, 2872, 1647, 1599, 1504, 1453, 1372, 
1307, 1296, 1198, 1176, 1152, 1093, 1016, 969, 867, 841, 815, 763, 735, 700, 661. 
 
HRMS (FAB, m/z): calc’d for C23H22O3S [M+·]+: 378.1290; found: 378.1283. 
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(S,E)-but-1-ene-1,3-diyldibenzene (3h) 
Prepared from (E)-(2-bromovinyl)benzene (1h, 37 mg, 0.2 mmol) and 1,3-
dioxoisoindolin-2-yl 2-phenylpropanoate (2, 59 mg, 0.2 mmol) according to 
General Procedure 3. The crude residue was purified by column 
chromatography (silica gel, hexane) to yield 3h (37 mg, 88% yield) in 96% ee as a colorless oil. 
 
Rf = 0.48 (silica gel, hexane, UV). 
 
Chiral SFC: (OJ-H, 2.5 mL/min, 5% IPA in CO2, λ = 254 nm): tR (minor) = 9.8 min, tR (major) 
= 10.9 min. 
 [𝒂]𝑫𝟐𝟓 = –35° (c = 1.0, CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.43 – 7.29 (m, 8H), 7.29 – 7.21 (m, 2H), 6.51 – 6.38 (m, 2H), 
3.73 – 3.65 (m, 1H), 1.52 (d, J = 7.0 Hz, 3H). 
 
13C NMR (101 MHz, CDCl3): δ 145.7, 137.7, 135.3, 128.6 (3C), 127.4, 127.2, 126.35, 126.27, 
42.7, 21.4. 
 
FTIR (NaCl, thin film, cm-1): 3080, 3058, 3024, 2964, 2928, 2871, 1599, 1492, 1448, 1371, 
1010, 964, 742, 692. 
 
HRMS (ESI-TOF, m/z): calc’d for C16H16 [M–H2+H]+: 207.1174; found: 207.1155. 
The optical rotation of 3h generated in the presence of (R,R,S,S)-4b was measured as [𝒂]𝑫𝟐𝟓 = –35° 
(c = 1.0, CHCl3). Lit: [𝒂]𝑫𝟐𝟓 = –21.1° (c = 1.42, CHCl3, S enantiomer, 95% ee).23  Based on the 
literature precedent, we assign our product as the S enantiomer.  
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(S,E)-2-methoxy-5-(3-phenylbut-1-en-1-yl)pyridine (3i) 
Prepared from (E)-5-(2-bromovinyl)-2-methoxypyridine (1i, 43 mg, 0.2 
mmol) and 1,3-dioxoisoindolin-2-yl 2-phenylpropanoate (2, 59 mg, 0.2 
mmol) according to General Procedure 3. The crude residue was 
purified by column chromatography (silica gel, 5% Et2O/hexane) to yield 3i (32 mg, 67% yield) 
in 95% ee as a colorless oil. 
 
Rf = 0.53 (silica gel, 10% EtOAc/hexane, UV). 
 
Chiral SFC: (OB-H, 2.5 mL/min, 15% IPA in CO2, λ = 280 nm): tR (major) = 5.0 min, 
tR (minor) = 6.9 min. 
 [𝒂]𝑫𝟐𝟓 = –33° (c = 1.0, CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 8.06 (d, J = 2.4 Hz, 1H), 7.62 (dd, J = 8.7, 2.5 Hz, 1H), 7.35 – 
7.28 (m, 2H), 7.28 – 7.18 (m, 3H), 6.67 (d, J = 8.6 Hz, 1H), 6.33 (d, J = 16.1 Hz, 1H), 6.26 (dd, J 
= 15.9, 6.3 Hz, 1H), 3.91 (s, 3H), 3.66 – 3.57 (m, 1H), 1.45 (d, J = 7.0 Hz, 3H). 
 
13C NMR (101 MHz, CDCl3): δ 163.4, 145.6, 145.3, 135.5, 134.7, 128.7, 127.4, 126.8, 126.4, 
124.7, 110.9, 53.6, 42.8, 21.3. 
 
FTIR (NaCl, thin film, cm-1): 2965, 1601, 1493, 1384, 1286, 1026, 962, 822, 762, 699. 
 
HRMS (FAB, m/z): calc’d for C16H17NO [M+H]+: 240.1388; found: 240.1398. 
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(S,E)-5-phenylhex-3-en-1-yl benzoate (3j) 
Prepared from (E)-4-bromobut-3-en-1-yl benzoate (1j, 51 mg, 0.2 mmol) 
and 1,3-dioxoisoindolin-2-yl 2-phenylpropanoate (2, 59 mg, 0.2 mmol) 
according to General Procedure 3. The crude residue was purified by 
column chromatography (silica gel, 5% Et2O/hexane) to yield 3j (49 mg, 88% yield) in 97% ee 
as a colorless oil. Spectral data matched those reported in literature.13 
 
Rf = 0.24 (silica gel, 5% Et2O/hexane, UV). 
 
Chiral SFC: (OJ-H, 2.5 mL/min, 10% IPA in CO2, λ = 254 nm): tR (major) = 5.2 min, tR (minor) 
= 6.1 min.  
 [𝒂]𝑫𝟐𝟓 = +5° (c =1.0, CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 8.04 – 8.00 (m, 2H), 7.59 – 7.53 (m, 1H), 7.46 – 7.40 (m, 2H), 
7.29 – 7.23 (m, 2H), 7.22 – 7.15 (m, 3H), 5.77 (ddt, J = 15.4, 6.8, 1.3 Hz, 1H), 5.52 (dtd, J = 
15.2, 6.8, 1.3 Hz, 1H), 4.36 (td, J = 6.7, 1.4 Hz, 2H), 3.50 – 3.42 (m, 1H), 2.54 – 2.46 (m, 2H), 
1.35 (d, J = 7.0 Hz, 3H). 
 
13C NMR (101 MHz, CDCl3): δ 166.7, 146.0, 138.3, 133.0, 130.5, 129.7, 128.5, 128.4, 127.3, 
126.2, 124.3, 64.4, 42.4, 32.2, 21.4. 
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(S,E)-(7-chlorohept-3-en-2-yl)benzene (3k) 
Prepared from (E)-1-bromo-5-chloropent-1-ene (1k, 37 mg, 0.2 mmol) 
and 1,3-dioxoisoindolin-2-yl 2-phenylpropanoate (2, 59 mg, 0.2 mmol) 
according to General Procedure 3. The crude residue was purified by 
column chromatography (silica gel, hexane) to yield 3k (29 mg, 69% yield) in 91% ee as a 
colorless oil. 
 
Rf = 0.29 (silica gel, hexane, UV/CAM). 
 
Chiral SFC: (OD-H, 2.5 mL/min, 1% IPA in CO2, λ = 210 nm): tR (minor) = 5.4 min, tR (major) 
= 6.0 min.  
 [𝒂]𝑫𝟐𝟓 = +9° (c =1.0, CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.35 – 7.29 (m, 2H), 7.25 – 7.18 (m, 3H), 5.69 (ddt, J = 15.3, 
6.8, 1.4 Hz, 1H), 5.43 (dtd, J = 15.1, 6.8, 1.1 Hz, 1H), 3.54 (t, J = 6.7 Hz, 2H), 3.50 – 3.40 (m, 
1H), 2.23 – 2.16 (m, 2H), 1.90 – 1.82 (m, 2H), 1.36 (d, J = 7.0 Hz, 3H). 
 
13C NMR (101 MHz, CDCl3): δ 146.3, 136.7, 128.5, 127.24, 127.17, 126.1, 44.6, 42.4, 32.4, 
29.7, 21.6. 
 
FTIR (NaCl, thin film, cm-1): 3025, 2962, 2929, 2871, 1601, 1492, 1450, 1371, 1297, 1017, 
969, 759, 698. 
 
HRMS (FAB, m/z): calc’d for C13H17Cl [M–H2+H]+: 207.0940; found: 207.0910. 
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S39 
(S,E)-dec-3-en-2-ylbenzene (3l) 
Prepared from (E)-1-bromooct-1-ene (1l, 38 mg, 0.2 mmol) and 
1,3-dioxoisoindolin-2-yl 2-phenylpropanoate (2, 59 mg, 0.2 mmol) 
according to General Procedure 3. The crude residue was purified 
by column chromatography (silica gel, hexane) to yield 3l (31 mg, 72% yield) in 94% ee as a 
colorless oil. 
 
Rf = 0.59 (silica gel, hexane, UV/CAM). 
 
Chiral SFC: (OJ-H, 2.5 mL/min, 1% IPA in CO2, λ = 210 nm): tR (minor) = 3.9 min, tR (major) 
= 4.5 min. 
 [𝒂]𝑫𝟐𝟓 = +4° (c = 0.9, CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.34 – 7.27 (m, 2H), 7.25 – 7.15 (m, 3H), 5.60 (ddt, J = 15.3, 
6.6, 1.4 Hz, 1H), 5.46 (dtd, J = 15.1, 6.6, 1.2 Hz, 1H), 3.47 – 3.38 (m, 1H), 2.06 – 1.97 (m, 2H), 
1.40 – 1.22 (m, 11H), 0.95 – 0.83 (m, 3H). 
 
13C NMR (101 MHz, CDCl3): δ 146.7, 135.0, 129.5, 128.4, 127.3, 126.0, 42.4, 32.7, 31.9, 29.6, 
29.0, 22.8, 21.7, 14.3. 
 
FTIR (NaCl, thin film, cm-1): 3025, 2959, 2925, 2854, 1492, 1451, 1371, 1016, 965, 758, 697. 
 
LRMS (GC-MS, m/z): calc’d for C16H24 [M]+: 216.2; found: 216.2. 
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S40 
(S,E)-trimethyl((5-phenylhex-3-en-1-yl)oxy)silane (3m) 
Prepared from (E)-4-bromobut-3-en-1-ol (1m, 30 mg, 0.2 mmol) and 
1,3-dioxoisoindolin-2-yl 2-phenylpropanoate (2, 59 mg, 0.2 mmol) 
according to General Procedure 3 with the exception that 2.0 equiv 
TMSBr was used instead of 1.0 equiv. The reaction was quenched with water instead of 1 M HCl 
to prevent decomposition of the primary silyl ether. Note: An acidic workup yielded a mixture of 
the silyl ether and alcohol product, however the alcohol was inseparable from the phthalimide 
byproduct. The crude residue was purified by column chromatography (florisil, hexane to 1% 
Et2O/hexane) to yield 3m (33 mg, 66% yield) as a colorless oil. Note: The two enantiomers of 
the racemic silyl ether were inseparable by chiral SFC. 
 
Rf = 0.67 (silica gel, 10% EtOAc/hexane, UV/CAM). 
 [𝒂]𝑫𝟐𝟓 = +6° (c = 1.0, CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.35 – 7.28 (m, 2H), 7.25 – 7.17 (m, 3H), 5.69 (ddt, J = 15.4, 
6.7, 1.3 Hz, 1H), 5.47 (dtd, J = 15.3, 6.9, 1.4 Hz, 1H), 3.61 (t, J = 7.0 Hz, 2H), 3.49 – 3.40 (m, 
1H), 2.28 (qt, J = 7.0, 1.1 Hz, 2H), 1.36 (d, J = 7.1 Hz, 3H), 0.13 (s, 9H). 
 
13C NMR (101 MHz, CDCl3): δ 146.3, 137.3, 128.5, 127.3, 126.1, 125.4, 62.7, 42.5, 36.2, 21.5, 
-0.3. 
 
FTIR (NaCl, thin film, cm-1): 2961, 2930, 2902, 2863, 1602, 1493, 1452, 1382, 1251, 1094, 
968, 940, 876, 841, 758, 748, 699. 
 
HRMS (FAB, m/z): calc’d for C15H24OSi [M+H]+: 249.1675; found: 249.1684. 
 
(S,E)-5-phenylhex-3-en-1-ol (S7) 
 
Deprotection of Silyl Ether: Silyl ether 3m (33.0 mg, 0.132 mmol, 1 equiv) was dissolved in a 
solution of acetic acid (0.5 mL), water (0.5 mL), and THF (2.5 mL) in a 20 mL vial equipped 
with a magnetic stir bar and stirred at room temperature for 15 min. The reaction was slowly 
quenched with a solution of saturated NaHCO3 until the pH was slightly basic (approx. 15 mL), 
Me
TMSO
Me
HOAcOH
H2O/THF, rt
Me
TMSO
   
 
S41 
extracted with Et2O (3 x 10 mL), dried with MgSO4, filtered, and concentrated under reduced 
pressure to yield S7 (22.6 mg, 97% yield) in 89% ee as a colorless oil. Spectral data matched 
those reported in literature.13 
 
Rf = 0.11 (silica gel, 10% EtOAc/hexane, UV/CAM). 
 
Chiral SFC: (OB-H, 2.5 mL/min, 3% IPA in CO2, λ = 210 nm): tR (minor) = 6.9 min, tR (major) 
= 7.5 min. 
 [𝒂]𝑫𝟐𝟓 = +9° (c = 1.0, CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.34 – 7.27 (m, 2H), 7.25 – 7.16 (m, 3H), 5.76 (ddt, J = 15.4, 
6.7, 1.4 Hz, 1H), 5.45 (dtd, J = 15.3, 7.0, 1.4 Hz, 1H), 3.65 (t, J = 6.3 Hz, 2H), 3.52 – 3.42 (m, 
1H), 2.30 (q, J = 6.3 Hz, 2H), 1.54 (s, 1H), 1.37 (d, J = 7.1 Hz, 3H).  
 
13C NMR (101 MHz, CDCl3): δ 146.1, 138.8, 128.6, 127.2, 126.2, 124.8, 62.2, 42.5, 36.0, 21.6. 
  
 
 
 
 
  
   
 
S42 
(S,E)-6-methyl-2-(3-phenylbut-1-en-1-yl)-1,3,6,2-dioxazaborocane-4,8-dione (3n) 
 Prepared from trans-1-bromovinylboronic acid MIDA ester (1n, 52 mg, 
0.2 mmol) and 1,3-dioxoisoindolin-2-yl 2-phenylpropanoate (2, 59 mg, 
0.2 mmol) according to General Procedure 3. The crude residue was 
purified by column chromatography (silica gel, 10% EtOAc/hexane to 100% EtOAc) to yield 3n 
(25 mg, 43% yield) in 97% ee as a yellow solid. Note: The 1H NMR contains two minor 
impurities that were identified as DMA and methyliminodiacetic acid. 
 
Rf = 0.35 (silica gel, EtOAc, UV/KMnO4). 
 
m.p. = 144–146 °C 
 
Chiral SFC: (OJ-H, 2.5 mL/min, 30% IPA in CO2, λ = 210 nm): tR (major) = 5.5 min, 
tR (minor) = 10.2 min. 
 [𝒂]𝑫𝟐𝟓 = +0.5° ± 1.1° (c = 1.0, CHCl3). Note: This compound shows low optical rotation. 
 
1H NMR (400 MHz, CDCl3): δ 7.32 – 7.23 (m, 2H), 7.21 – 7.13 (m, 3H), 6.32 (dd, J = 17.7, 6.4 
Hz, 1H), 5.38 (dd, J = 17.7, 1.5 Hz, 1H), 3.92 (dd, J = 16.7, 4.5 Hz, 2H), 3.59 (dd, J = 16.8, 13.9 
Hz, 2H), 3.54 – 3.46 (m, 1H), 2.69 (s, 3H), 1.36 (d, J = 7.0 Hz, 3H). 
 
13C NMR (101 MHz, CDCl3): δ 168.34, 168.27, 151.7, 145.3, 128.6, 127.4, 126.3, 61.53, 61.49, 
47.0, 44.8, 20.8. 
 
FTIR (NaCl, thin film, cm-1): 2963, 1762, 1636, 1492, 1338, 1290, 1246, 1193, 1154, 1126, 
1090, 1025, 1007, 956, 867, 761, 702. 
 
HRMS (FAB, m/z): calc’d for C15H18BNO4 [M+H]+: 288.1407; found: 288.1414. 
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S43 
(S,E)-trimethyl(3-phenylbut-1-en-1-yl)silane (3o) 
Prepared from (E)-(2-bromovinyl)trimethylsilane (1o, 36 mg, 0.2 mmol) and 
1,3-dioxoisoindolin-2-yl 2-phenylpropanoate (2, 59 mg, 0.2 mmol) according 
to General Procedure 3. Vinyl bromide 1o is reported to be air sensitive, and 
was added to the reaction while inside the glovebox. The crude residue was purified by column 
chromatography (silica gel, hexane) to yield 3o (28 mg, 68% yield) in 97% ee as a colorless oil. 
 
Rf = 0.65 (silica gel, hexane, UV/CAM). 
 
Chiral SFC: (OJ-H, 2.5 mL/min, CO2, λ = 210 nm): tR (major) = 1.8 min, tR (minor) = 2.0 min.  
 [𝒂]𝑫𝟐𝟓 = –2.4° ± 0.2° (c = 0.9, CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.35 – 7.28 (m, 2H), 7.24 – 7.18 (m, 3H), 6.19 (dd, J = 18.6, 5.9 
Hz, 1H), 5.68 (dd, J = 18.6, 1.6 Hz, 1H), 3.52 – 3.44 (m, 1H), 1.36 (d, J = 7.0 Hz, 3H), 0.06 (s, 
9H). 
 
13C NMR (101 MHz, CDCl3): δ 150.8, 145.8, 128.5, 128.1, 127.5, 126.2, 45.6, 20.9, -1.0. 
 
FTIR (NaCl, thin film, cm-1): 3028, 2958, 1612, 1602, 1492, 1452, 1248, 1009, 987, 868, 837, 
759, 698. 
 
LRMS (GC-MS, m/z): calc’d for C13H20Si [M]+: 204.1; found: 204.1. 
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S44 
(S,E)-4,4’-(but-1-ene-1,3-diyl)bis(methoxybenzene) (7a) 
Prepared from (E)-1-(2-bromovinyl)-4-methoxybenzene (1a, 43 
mg, 0.2 mmol) and 1,3-dioxoisoindolin-2-yl 2-(4-methoxyphenyl)-
propanoate (6a, 65 mg, 0.2 mmol) according to General Procedure 
3. The crude residue was purified by column chromatography (silica gel, 10% toluene/hexane 
then 10% Et2O/hexane) to yield 7a (42 mg, 78% yield) in 93% ee as a white solid. Spectral data 
matched those reported in literature.13 
 
Rf = 0.45 (silica gel, 10% EtOAc/hexane, UV). 
 
m.p. = 51–59 °C 
 
Chiral SFC: (AD-H, 2.5 mL/min, 20% IPA in CO2, λ = 235 nm): tR (major) = 7.0 min, 
tR (minor) = 8.5 min. 
 [𝒂]𝑫𝟐𝟓 = –34° (c = 1.0, CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.32 (d, J = 8.7 Hz, 2H), 7.22 (d, J = 8.5 Hz, 2H), 6.89 (d, J = 
8.8 Hz, 2H), 6.86 (d, J = 8.8 Hz, 2H), 6.37 (d, J = 16.0 Hz, 1H), 6.25 (dd, J = 15.9, 6.6 Hz, 1H), 
3.82 (s, 3H), 3.81 (s, 3H), 3.65 – 3.55 (m, 1H), 1.46 (d, J = 7.0 Hz, 3H). 
 
13C NMR (101 MHz, CDCl3): δ 158.9, 158.0, 138.1, 133.6, 130.5, 128.3, 127.7, 127.3, 114.0, 
113.9, 55.4 (2C), 41.8, 21.6. 
 
 
 
  
MeO
Me
OMe
   
 
S45 
(S,E)-1-methoxy-4-(3-(4-(trifluoromethyl)phenyl)but-1-en-1-yl)benzene (7b) 
Prepared from (E)-1-(2-bromovinyl)-4-methoxybenzene (1a, 43 
mg, 0.2 mmol) and 1,3-dioxoisoindolin-2-yl 2-(4-(trifluoromethyl)-
phenyl)propanoate (6b, 73 mg, 0.2 mmol) according to General 
Procedure 3. The crude residue was purified by column chromatography (silica gel, 5% 
toluene/hexane) to yield 7b (40 mg, 65% yield) in 88% ee as a white solid. 
 
Rf = 0.48 (silica gel, 10% EtOAc/hexane, UV). 
 
m.p. = 67–70 °C 
 
Chiral SFC: (OB-H, 2.5 mL/min, 5% IPA in CO2, λ = 254 nm): tR (major) = 6.5 min, 
tR (minor) = 7.5 min. 
 [𝒂]𝑫𝟐𝟓 = –39° (c = 1.0, CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.58 (d, J = 8.1 Hz, 2H), 7.39 (d, J = 8.4 Hz, 2H), 7.30 (d, J = 
8.7 Hz, 2H), 6.85 (d, J = 8.8 Hz, 2H), 6.38 (d, J = 16.0 Hz, 1H), 6.21 (dd, J = 15.9, 6.8 Hz, 1H), 
3.81 (s, 3H), 3.73 – 3.64 (m, 1H), 1.48 (d, J = 7.0 Hz, 3H). 
 
13C NMR (101 MHz, CDCl3): δ 159.1, 150.1 (q, JC-F = 1.4 Hz), 132.0, 130.1, 128.8, 128.6 (q, 
JC-F = 32.3 Hz), 127.8, 127.4, 125.5 (q, JC-F = 3.8 Hz), 124.5 (q, JC-F = 271.9 Hz), 114.1, 55.4, 
42.6, 21.3. 
 
19F NMR (282 MHz, CDCl3): δ -65.4. 
 
FTIR (NaCl, thin film, cm-1): 2965, 1608, 1512, 1252, 1174, 1164, 1122, 1069, 1036, 1016, 
967, 840, 818. 
 
HRMS (EI, m/z): calc’d for C18H17F3O [M+·]+: 306.1232; found: 306.1241. 
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S46 
(S,E)-1-bromo-4-(4-(4-methoxyphenyl)but-3-en-2-yl)benzene (7c) 
Prepared from (E)-1-(2-bromovinyl)-4-methoxybenzene (1a, 43 mg, 
0.2 mmol) and 1,3-dioxoisoindolin-2-yl 2-(4-bromophenyl)-
propanoate (6c, 75 mg, 0.2 mmol) according to General Procedure 3. 
The crude residue was purified by column chromatography (silica gel, 5 to 10% toluene/hexane) 
to yield 7c (51 mg, 80% yield) in 90% ee as a white solid. Spectral data matched those reported 
in literature.13 
 
Rf = 0.59 (silica gel, 10% EtOAc/hexane, UV). 
 
m.p. = 74–76 °C 
 
Chiral SFC: (OB-H, 2.5 mL/min, 35% IPA in CO2, λ = 254 nm): tR (major) = 5.3 min, 
tR (minor) = 8.5 min.  
 [𝒂]𝑫𝟐𝟓 = –32° (c = 1.0, CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.45 (d, J = 8.5 Hz, 2H), 7.30 (d, J = 8.6 Hz, 2H), 7.16 (d, J = 
8.3 Hz, 2H), 6.86 (d, J = 8.8 Hz, 2H), 6.36 (d, J = 16.0 Hz, 1H), 6.20 (dd, J = 15.9, 6.7 Hz, 1H), 
3.81 (s, 3H), 3.64 – 3.55 (m, 1H), 1.45 (d, J = 7.0 Hz, 3H). 
 
13C NMR (101 MHz, CDCl3): δ 159.0, 145.0, 132.5, 131.6, 130.2, 129.2, 128.4, 127.4, 120.0, 
114.0, 55.4, 42.1, 21.3. 
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S47 
(S,E)-1-fluoro-4-(4-(4-methoxyphenyl)but-3-en-2-yl)benzene (7d) 
Prepared from (E)-1-(2-bromovinyl)-4-methoxybenzene (1a, 43 mg, 
0.2 mmol) and 1,3-dioxoisoindolin-2-yl 2-(4-fluorophenyl)-
propanoate (6d, 63 mg, 0.2 mmol) according to General Procedure 3. 
The crude residue was purified by column chromatography (silica gel, 5 to 30% toluene/hexane) 
to yield 7d (44 mg, 85% yield) in 92% ee as a colorless oil. Spectral data matched those reported 
in literature.13 
 
Rf = 0.70 (silica gel, 10% EtOAc/hexane, UV). 
 
Chiral SFC: (OB-H, 2.5 mL/min, 15% IPA in CO2, λ = 280 nm): tR (major) = 5.9 min, 
tR (minor) = 8.3 min.  
 [𝒂]𝑫𝟐𝟓 = –29° (c = 1.0, CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.34 – 7.28 (m, 2H), 7.28 – 7.20 (m, 2H), 7.06 – 6.98 (m, 2H), 
6.89 – 6.83 (m, 2H), 6.40 – 6.32 (m, 1H), 6.23 (dd, J = 15.9, 6.7 Hz, 1H), 3.81 (s, 3H), 3.67 – 
3.58 (m, 1H), 1.46 (d, J = 7.0 Hz, 3H). 
 
13C NMR (101 MHz, CDCl3): δ 161.5 (d, JC-F = 243.7 Hz), 159.0, 141.6 (d, JC-F = 3.1 Hz), 
133.0, 130.3, 128.8 (d, JC-F = 7.8 Hz), 128.1, 127.4, 115.3 (d, JC-F = 21.2 Hz), 114.1, 55.4, 41.9, 
21.6. 
 
19F NMR (282 MHz, CDCl3): δ -123.56 (tt, JF-H = 8.9, 5.4 Hz). 
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S48 
(S,E)-4-(4-(4-methoxyphenyl)but-3-en-2-yl)-N,N-dimethylaniline (7e) 
Prepared from (E)-1-(2-bromovinyl)-4-methoxybenzene (1a, 43 
mg, 0.2 mmol) and 1,3-dioxoisoindolin-2-yl 2-(4-(dimethyl-
amino)phenyl)propanoate (6e, 68 mg, 0.2 mmol) according to 
General Procedure 3. The reaction was quenched with water instead of 1 M HCl. The crude 
residue was purified by column chromatography (silica gel, hexane to 10% Et2O/hexane) to yield 
7e (37 mg, 66% yield) in 94% ee as a white solid. 
 
Rf = 0.28 (silica gel, 10% EtOAc/hexane, UV). 
 
m.p. = 72–75 °C 
 
Chiral SFC: (AD-H, 2.5 mL/min, 20% IPA in CO2, λ = 280 nm): tR (major) = 8.2 min, 
tR (minor) = 10.6 min. 
 [𝒂]𝑫𝟐𝟓 = –29° (c = 1.1, CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.29 (d, J = 8.7 Hz, 2H), 7.15 (d, J = 8.5 Hz, 2H), 6.83 (d, J = 
8.8 Hz, 2H), 6.73 (d, J = 8.7 Hz, 2H), 6.34 (dd, J = 16.2, 0.8 Hz, 1H), 6.23 (dd, J = 15.9, 6.6 Hz, 
1H), 3.80 (s, 3H), 3.58 – 3.50 (m, 1H), 2.93 (s, 6H), 1.42 (d, J = 7.1 Hz, 3H). 
 
13C NMR (101 MHz, CDCl3): δ 158.8, 149.3, 134.1, 130.7, 128.0, 127.3, 114.0, 113.1, 55.4, 
41.6, 41.0, 21.5. 
 
FTIR (NaCl, thin film, cm-1): 2958, 1608, 1518, 1509, 1456, 1341, 1249, 1173, 1034, 966, 948, 
815. 
 
HRMS (FAB, m/z): calc’d for C19H23NO [M+·]+: 281.1780; found: 281.1774. 
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S49 
(S,E)-1,2-dichloro-4-(4-(4-methoxyphenyl)but-3-en-2-yl)benzene (7f) 
Prepared from (E)-1-(2-bromovinyl)-4-methoxybenzene (1a, 43 mg, 
0.2 mmol) and 1,3-dioxoisoindolin-2-yl 2-(3,4-dichlorophenyl)-
propanoate (6f, 73 mg, 0.2 mmol) according to General Procedure 3. 
The crude residue was purified by column chromatography (silica gel, hexane to 5% 
Et2O/hexane) to yield 7f (48 mg, 77% yield) in 82% ee as a colorless oil. 
 
Rf = 0.51 (silica gel, 10% EtOAc/hexane, UV). 
 
Chiral SFC: (OB-H, 2.5 mL/min, 25% IPA in CO2, λ = 280 nm): tR (major) = 6.5 min, 
tR (minor) = 9.0 min. 
 [𝒂]𝑫𝟐𝟓 = –26° (c = 1.1, CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.37 (d, J = 8.3 Hz, 1H), 7.35 (d, J = 2.1 Hz, 1H), 7.32 – 7.27 
(m, 2H), 7.10 (ddd, J = 8.2, 2.1, 0.6 Hz, 1H), 6.87 – 6.82 (m, 2H), 6.35 (dd, J = 15.9, 1.3 Hz, 
1H), 6.15 (dd, J = 15.9, 6.8 Hz, 1H), 3.81 (s, 3H), 3.62 – 3.53 (m, 1H), 1.43 (d, J = 7.0 Hz, 3H). 
 
13C NMR (101 MHz, CDCl3): δ 159.2, 146.3, 132.4, 131.7, 130.5, 130.1, 130.0, 129.4, 128.9, 
127.4, 127.0, 114.1, 55.4, 41.9, 21.2. 
 
FTIR (NaCl, thin film, cm-1): 2964, 1607, 1511, 1466, 1299, 1250, 1174, 1106, 1030, 967, 815. 
 
HRMS (FAB, m/z): calc’d for C17H16Cl2O [M+·]+: 306.0578; found: 306.0582. 
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S50 
(S,E)-1-methoxy-4-(3-phenylpent-1-en-1-yl)benzene (7g) 
Prepared from (E)-1-(2-bromovinyl)-4-methoxybenzene (1a, 43 mg, 0.2 
mmol) and 1,3-dioxoisoindolin-2-yl 2-phenylbutanoate (6g, 62 mg, 0.2 
mmol) according to General Procedure 3. The crude residue was 
purified by column chromatography (silica gel, 10 to 20% toluene/hexane) to yield 7g (40 mg, 
80% yield) in 97% ee as a colorless oil. Spectral data matched those reported in literature.13 
 
Rf = 0.59 (silica gel, 10% EtOAc/hexane, UV). 
 
Chiral SFC: (OB-H, 2.5 mL/min, 15% IPA in CO2, λ = 254 nm): tR (minor) = 8.0 min, 
tR (major) = 9.9 min. 
 [𝒂]𝑫𝟐𝟓 = –46° (c = 1.0, CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.37 – 7.19 (m, 7H), 6.84 (d, J = 8.8 Hz, 2H), 6.37 (d, J = 15.8 
Hz, 1H), 6.21 (dd, J = 15.8, 7.8 Hz, 1H), 3.80 (s, 3H), 3.35 – 3.26 (m, 1H), 1.90 – 1.78 (m, 2H), 
0.93 (t, J = 7.4 Hz, 3H). 
 
13C NMR (101 MHz, CDCl3): δ 158.9, 144.9, 132.2, 130.6, 128.9, 128.6, 127.8, 127.3, 126.2, 
114.0, 55.4, 51.1, 29.0, 12.5. 
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S51 
(S,E)-(4-(4-methoxyphenyl)but-3-ene-1,2-diyl)dibenzene (7h) 
Prepared from (E)-1-(2-bromovinyl)-4-methoxybenzene (1a, 43 mg, 0.2 
mmol) and 1,3-dioxoisoindolin-2-yl 2,3-diphenylpropanoate (6h, 74 
mg, 0.2 mmol) according to General Procedure 3. The crude residue 
was purified by column chromatography (silica gel, 10% toluene/hexane then 10% Et2O/hexane) 
to yield 7h (49 mg, 78% yield) in 95% ee as a white solid. Spectral data matched those reported 
in literature.13 
 
Rf = 0.48 (silica gel, 10% EtOAc/hexane, UV). 
 
m.p. = 72–73 °C 
 
Chiral SFC: (AS-H, 2.5 mL/min, 10% IPA in CO2, λ = 254 nm): tR (minor) = 6.0 min, 
tR (major) = 6.5 min. 
 [𝒂]𝑫𝟐𝟓 = +19° (c = 1.0, CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.34 – 7.13 (m, 10H), 7.10 (d, J = 8.8 Hz, 2H), 6.83 (d, J = 8.8 
Hz, 2H), 6.30 (dd, J = 15.9, 6.3 Hz, 1H), 6.25 (d, J = 15.9 Hz, 1H), 3.80 (s, 3H), 3.78 – 3.67 (m, 
1H), 3.19 – 3.06 (m, 2H). 
 
13C NMR (101 MHz, CDCl3): δ 158.9, 144.1, 140.2, 131.3, 130.4, 129.53, 129.49, 128.5, 128.2, 
128.0, 127.4, 126.4, 126.0, 114.0, 55.4, 51.0, 42.9. 
 
  
MeO
Ph
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(S,E)-1-methoxy-4-(4-methyl-3-phenylpent-1-en-1-yl)benzene (7i) 
Prepared from (E)-1-(2-bromovinyl)-4-methoxybenzene (1a, 43 mg, 0.2 
mmol) and 1,3-dioxoisoindolin-2-yl 3-methyl-2-phenylbutanoate (6i, 65 
mg, 0.2 mmol) according to General Procedure 3. The crude residue 
was purified by column chromatography (silica gel, 10 to 20% toluene/hexane) to yield 7i (25 
mg, 47% yield) in 97% ee as a white solid.  
 
Rf = 0.58 (silica gel, 10% EtOAc/hexane, UV). 
 
m.p. = 67–68 °C 
 
Chiral SFC: (AS-H, 2.5 mL/min, 10% IPA in CO2, λ = 254 nm): tR (minor) = 4.8 min, 
tR (major) = 6.1 min. 
 [𝒂]𝑫𝟐𝟓 = –39° (c = 1.0, CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.34 – 7.28 (m, 4H), 7.26 – 7.17 (m, 3H), 6.84 (d, J = 8.8 Hz, 
2H), 6.36 (d, J = 15.7 Hz, 1H), 6.26 (dd, J = 15.7, 8.8 Hz, 1H), 3.80 (s, 3H), 3.04 (t, J = 8.8 Hz, 
1H), 2.14 – 1.96 (m, 1H), 1.02 (d, J = 6.7 Hz, 3H), 0.82 (d, J = 6.6 Hz, 3H). 
 
13C NMR (101 MHz, CDCl3): δ 158.9, 144.7, 131.2, 130.6, 129.8, 128.5, 128.1, 127.3, 126.1, 
114.0, 57.8, 55.4, 33.4, 21.3, 21.1. 
 
FTIR (NaCl, thin film, cm-1): 2953, 1600, 1509, 1450, 1251, 1027, 966, 838, 701. 
 
LRMS (GC-MS, m/z): calc’d for C19H22O [M]+: 266.2; found: 266.1. 
 
  
MeO
Me Me
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(S,E)-tert-butyl((4-(4-methoxyphenyl)-2-phenylbut-3-en-1-yl)oxy)dimethylsilane (7j)  
Prepared from (E)-1-(2-bromovinyl)-4-methoxybenzene (1a, 43 mg, 0.2 
mmol) and 1,3-dioxoisoindolin-2-yl 3-((tert-butyldimethylsilyl)oxy)-2-
phenylpropanoate (6j, 74 mg, 0.2 mmol) according to General 
Procedure 3. The crude residue was purified by column chromatography (silica gel, 10% 
toluene/hexane then 10% Et2O/hexane) to yield 7j (43 mg, 58% yield) in 98% ee as a colorless 
oil. 
 
Rf = 0.55 (silica gel, 10% EtOAc/hexane, UV). 
 
Chiral SFC: (OJ-H, 2.5 mL/min, 10% IPA in CO2, λ = 254 nm): tR (major) = 3.4 min, tR (minor) 
= 5.8 min. 
 [𝒂]𝑫𝟐𝟓 = –14° (c = 1.0, CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.39 – 7.29 (m, 6H), 7.28 – 7.23 (m, 1H), 6.87 (d, J = 8.8 Hz, 
2H), 6.44 (d, J = 16.0 Hz, 1H), 6.34 (dd, J = 15.9, 7.2 Hz, 1H), 3.98 – 3.89 (m, 2H), 3.83 (s, 3H), 
3.70 – 3.63 (m, 1H), 0.89 (s, 9H), 0.02 (s, 3H), 0.01 (s, 3H). 
 
13C NMR (101 MHz, CDCl3): δ 159.0, 142.3, 130.7, 130.5, 128.8, 128.45, 128.42, 127.4, 126.6, 
114.0, 67.5, 55.4, 51.8, 26.0, 18.4, -5.2, -5.3. 
 
FTIR (NaCl, thin film, cm-1): 2953, 2928, 2892, 2855, 1607, 1511, 1463, 1250, 1174, 1106, 
1036, 836, 775, 699. 
 
HRMS (FAB, m/z): calc’d for C23H32O2Si [M–H2+H]+: 367.2093; found: 367.2081. 
 
  
MeO
OTBS
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(S,E)-1-methoxy-4-(3-phenylhexa-1,5-dien-1-yl)benzene (7k)  
Prepared from (E)-1-(2-bromovinyl)-4-methoxybenzene (1a, 43 mg, 0.2 
mmol) and 1,3-dioxoisoindolin-2-yl 2-phenylpent-4-enoate (6k, 53 mg, 
0.2 mmol) according to General Procedure 3. The crude residue was 
purified by column chromatography (silica gel, 5 to 20% toluene/hexane) to yield 7k (42 mg, 
79% yield) in 96% ee as a colorless oil. 
 
Rf = 0.55 (silica gel, 10% EtOAc/hexane, UV). 
 
Chiral SFC: (OJ-H, 2.5 mL/min, 10% IPA in CO2, λ = 254 nm): tR (minor) = 7.8 min, tR (major) 
= 8.5 min. 
 [𝒂]𝑫𝟐𝟓 = –19° (c =1.0, CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.31 – 7.14 (m, 7H), 6.78 (d, J = 8.8 Hz, 2H), 6.30 (d, J = 15.9 
Hz, 1H), 6.18 (dd, J = 15.8, 7.5 Hz, 1H), 5.73 (ddt, J = 17.1, 10.2, 6.9 Hz, 1H), 5.01 (ddt, J = 
17.0, 2.0, 1.5 Hz, 1H), 4.95 (ddt, J = 10.2, 2.1, 1.0 Hz, 1H), 3.74 (s, 3H), 3.50 – 3.42 (m, 1H), 
2.57 – 2.51 (m, 2H). 
 
13C NMR (101 MHz, CDCl3): δ 159.0, 144.2, 136.8, 131.5, 130.4, 129.2, 128.6, 127.8, 127.4, 
126.4, 116.4, 114.0, 55.4, 49.1, 40.4. 
 
FTIR (NaCl, thin film, cm-1): 3025, 2913, 2834, 1606, 1509, 1246, 1173, 1032, 963, 911, 756, 
698. 
 
HRMS (EI, m/z): calc’d for C19H20O [M+·]+: 264.1514; found: 264.1521. 
 
  
MeO
   
 
S55 
(S,E)-1-(6-chloro-3-phenylhex-1-en-1-yl)-4-methoxybenzene (7l) 
Prepared from (E)-1-(2-bromovinyl)-4-methoxybenzene (1a, 43 mg, 
0.2 mmol) and 1,3-dioxoisoindolin-2-yl 5-chloro-2-phenylpentanoate 
(6l, 72 mg, 0.2 mmol) according to General Procedure 3. The crude 
residue was purified by column chromatography (silica gel, 5% Et2O/hexane) to yield 7l (52 mg, 
87% yield) in 93% ee as a colorless oil.  
 
Rf = 0.53 (silica gel, 10% EtOAc/hexane, UV). 
 
Chiral SFC: (AS-H, 2.5 mL/min, 15% IPA in CO2, λ = 254 nm): tR (minor) = 3.7 min, 
tR (major) = 4.7 min. 
 [𝒂]𝑫𝟐𝟓 = –21° (c = 1.0, CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.37 – 7.21 (m, 7H), 6.85 (d, J = 8.8 Hz, 2H), 6.38 (d, J = 15.8 
Hz, 1H), 6.20 (dd, J = 15.8, 7.9 Hz, 1H), 3.81 (s, 3H), 3.56 (t, J = 6.5 Hz, 2H), 3.46 – 3.38 (m, 
1H), 2.02 – 1.92 (m, 2H), 1.92 – 1.69 (m, 2H). 
 
13C NMR (101 MHz, CDCl3): δ 159.0, 144.2, 131.5, 130.2, 129.2, 128.7, 127.7, 127.4, 126.5, 
114.0, 55.4, 48.7, 45.2, 33.2, 30.8. 
 
FTIR (NaCl, thin film, cm-1): 2915, 1605, 1491, 1438, 1509, 1246, 1173, 1031, 964. 
 
HRMS (FAB, m/z): calc’d for C19H21ClO [M+·]+: 300.1281; found: 300.1274. 
 
  
MeO
Cl
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(S,E)-(3-methoxy-3-phenylprop-1-en-1-yl)trimethylsilane (9) 
Prepared from (E)-(2-bromovinyl)trimethylsilane (1o, 36 mg, 0.2 mmol) and 
1,3-dioxoisoindolin-2-yl 2-methoxy-2-phenylacetate (8, 62 mg, 0.2 mmol) 
according to General Procedure 3. The crude residue was purified by column 
chromatography (silica gel, 0 to 3% Et2O/hexane) to yield 9 (26 mg, 59% yield) in 91% ee as a 
colorless oil. 
 
Rf = 0.62 (silica gel, 10% EtOAc/hexane, UV/CAM). 
 
Chiral SFC: (OD-H, 2.5 mL/min, 1% IPA in CO2, λ = 210 nm): tR (minor) = 2.6 min, tR (major) 
= 5.9 min.  
 [𝒂]𝑫𝟐𝟓 = +8° (c = 0.6, CHCl3). 
 
1H NMR (400 MHz, CDCl3): δ 7.40 – 7.27 (m, 5H), 6.10 (dd, J = 18.6, 5.9 Hz, 1H), 5.93 (dd, J 
= 18.6, 1.2 Hz, 1H), 4.61 (d, J = 5.8 Hz, 1H), 3.32 (s, 3H), 0.07 (s, 9H). 
 
13C NMR (101 MHz, CDCl3): δ 145.7, 140.9, 131.9, 128.6, 127.7, 127.1, 86.6, 56.6, -1.2. 
 
FTIR (NaCl, thin film, cm-1): 2955, 2820, 1453, 1248, 1100, 990, 863, 838, 760, 699. 
 
HRMS (FAB, m/z): calc’d for C13H20Osi [M–H2+H]+: 219.1205; found: 219.1191. 
 
  
TMS
OMe
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(E)-1-(3-cyclopropyl-3-phenylprop-1-en-1-yl)-4-methoxybenzene (11a) 
1-methoxy-4-((1E,5E)-6-phenylhexa-1,5-dien-1-yl)benzene (11b) 
1-methoxy-4-((1E,4E)-3-methyl-5-phenylpenta-1,4-dien-1-yl)benzene (11c) 
  
Prepared from (E)-1-(2-bromovinyl)-4-methoxybenzene (1a, 43 mg, 0.2 mmol) and 1,3-
dioxoisoindolin-2-yl 2-cyclopropyl-2-phenylacetate (10, 64 mg, 0.2 mmol) according to General 
Procedure 3. The crude residue was purified by column chromatography (silica gel, hexane to 
30% toluene/hexane) to yield a mixture of 11a–c (22 mg, 42% yield) as a colorless oil. The 
reaction was repeated with 5 mol % and 20 mol % of 4b, yielding a mixture of 11a–c in 44% and 
49% yield, respectively. Three products are confirmed by GC-MS (extract ion m/z = 264). 
Distinct 1H/13C signals and coupling correlations are confirmed by 1H, 13C, COSY, HSQC, and 
HMBC NMR spectroscopy. 
 
NMR data for 11a–c with 20 mol % 4b: 
1H NMR (400 MHz, CDCl3): δ 7.42 – 7.18 (m, 7H), 6.86 (dq, J = 8.9, 2.5 Hz, 2H), 6.49 – 6.36 
(m, 1.8H), 6.34 – 6.08 (m, 1.82H), 3.81 (s, 3H), 3.20 (qt, J = 6.9, 1.3 Hz, 0.1H, 11c), 2.76 (ddd, J 
= 8.6, 6.9, 1.2 Hz, 0.2H, 11a), 2.49 – 2.31 (m, 2.8H, 11b), 1.31 (d, J = 6.9 Hz, 0.3H, 11c), 1.23 – 
1.13 (m, 0.2H, 11a), 0.68 (dddd, J = 9.1, 8.0, 5.3, 4.1 Hz, 0.2H, 11a), 0.56 (dddd, J = 9.4, 8.0, 
5.2, 4.1 Hz, 0.2H, 11a), 0.40 – 0.31 (m, 0.2H, 11a), 0.28 (dtd, J = 9.3, 5.2, 4.2 Hz, 0.2H, 11a). 
 
13C NMR (101 MHz, CDCl3): δ 158.9, 158.8, 144.6, 137.9, 137.8, 134.7, 132.2, 131.2, 130.7, 
130.5, 130.4, 130.3, 129.8, 129.0, 128.7, 128.6, 128.5, 128.3, 128.0, 127.9, 127.4, 127.3, 127.2, 
127.1, 127.0, 126.4, 126.2, 126.1, 114.03, 114.02, 55.4, 53.2, 40.2, 33.2, 33.0, 20.5, 16.4, 4.9, 
4.4. 
 
FTIR (NaCl, thin film, cm-1): 3026, 2931, 2837, 1607, 1511, 1252, 1176, 1034, 966, 800, 692. 
 
LRMS (GC-MS, m/z): calc’d for C19H20O [M]+: 264.2; found: 3 products, 264.1, 264.1, 264.2. 
  
MeO
Ph
Ph
MeO MeO
Me
Ph
11b11a 11c
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11c 11a 
11b 
11c 
11a 
11b 
11c 11a 
11b 
Ratios of 11a–c were determined by 1H NMR analysis: 
 
 
 
5 mol % 4b:         10 mol % 4b:             20 mol % 4b: 
 
 
 
 
 
 
 
Integration of 11b was divided by 4 to account for the contribution of 4 protons in the multiplet. 
 
 
NMR Integrations 
  Nickel 
Catalyst 
Cyclopropane 
(11a) 
Linear 
(11b) 
Branched 
(11c) 
Ring Closed 
Total 
Ring Open 
Total 
5% 1.00 7.21 0.25 1.00 7.46 
10% 1.00 5.43 0.44 1.00 5.87 
20% 1.00 3.38 0.55 1.00 3.93 
 
  
MeO
Ph
Ph
MeO MeO
Me
Ph
11b11a 11c
H
H H
H H
H
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e. Comparison of Benzyl Cl and NHP Ester %ee Values 
 
 
Table S3. Product %ee Values using Conditions for Benzyl Chlorides or NHP Esters 
 
PMP
Br +
PMP
R
Ar
Cl
Ar
R
4a (10 mol %)
Mn (3.0 equiv)
NaI (0.5 equiv)
DMA, 0 °C, 6 h
PMP
Br +
PMP
R
Ar
NHP
O
Ar
R
4b (10 mol %)
TDAE (1.5 equiv)
NaI (0.5 equiv)
TMSBr (1.0 equiv)
DMA, –7 °C, 16 h
Condition A:
Condition B:
Product ee(%)c
3a
4-OMe
4-CF3
4-Br
4-F
7a
7b
7c
3,4-Cl2
--
7d
7f
93
88
90
92
82
97
-- 96
7g
-- 957h
-- 987j
-- 977i
aValues reported in Reference 13 with ligand L and NiCl2(dme). bValues obtained 
using the conditions reported in Reference 13 and with Ni complex 4a prepared 
with the same batch of ligand used in this manuscript. cValues reported in this 
manuscript (Table 2 and Table 3). dThe ee was improved to 79% with 2 equiv 
vinyl bromide.
4-NMe27e 95
-- 937l
-- 967k
3-chlorobutane
2-butene
Ar R
Me
Me
Me
Me
Me
Me
Me
Et
Bn
iPr
(CH2)OTBS
ee(%)b
93
87
90
90
77d
97
96
92
--
97
--
--
--
ee(%)a
93
--
90
89
--
97
93
93
--
--
--
--
--
A B
Conditions:
A
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8. Chiral SFC Traces (Note: Racemic samples made with scalemic ligand.) 
 
3a (Figure 1): racemic 
 
 
 
 
 
 
 
 
3a (Figure 1): enantioenriched, 96% ee 
 
 
 
 
  
MeO
Me
MeO
Me
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3b (Figure 1): racemic 
 
 
 
 
 
 
 
3b (Figure 1): enantioenriched, 95% ee 
 
 
 
 
  
Me
Me
Me
Me
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3c (Figure 1): racemic 
 
 
 
 
 
 
 
3c (Figure 1): enantioenriched, 97% ee 
 
 
 
 
  
Me2N
Me
Me2N
Me
   
 
S65 
3d (Figure 1): racemic 
 
 
 
 
 
 
 
3d (Figure 1): enantioenriched, 93% ee 
 
 
 
 
  
F3C
Me
F3C
Me
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3e (Figure 1): racemic 
 
 
 
 
 
 
 
3e (Figure 1): enantioenriched, 94% ee 
 
 
 
 
  
NC
Me
NC
Me
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3f (Figure 1): racemic 
 
 
 
 
 
 
 
3f (Figure 1): enantioenriched, 95% ee 
 
 
 
 
  
MeO2C
Me
MeO2C
Me
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3g (Figure 1): racemic 
 
 
 
 
 
 
 
3g (Figure 1): enantioenriched, 94% ee 
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Me
TsO
Me
   
 
S69 
3h (Figure 1): racemic 
 
 
 
 
 
 
 
3h (Figure 1): enantioenriched, 96% ee 
 
 
 
 
  
Me
Me
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3i (Figure 1): racemic 
 
 
 
 
 
 
 
3i (Figure 1): enantioenriched, 95% ee 
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NMeO
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3j (Figure 1): racemic 
 
 
 
 
 
 
 
3j (Figure 1): enantioenriched, 97% ee 
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Me
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3k (Figure 1): racemic 
 
 
 
 
 
 
 
3k (Figure 1): enantioenriched, 91% ee 
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Cl
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Cl
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3l (Figure 1): racemic 
 
 
 
 
 
 
 
3l (Figure 1): enantioenriched, 94% ee 
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S7 (de-silylated 3m, Figure 1): racemic 
 
 
 
 
 
 
 
S7 (de-silylated 3m, Figure 1): enantioenriched, 89% ee 
 
 
 
 
 
 
 
 
  
Me
HO
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3n (Figure 1): racemic 
 
 
 
 
 
 
 
3n (Figure 1): enantioenriched, 97% ee  
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3o (Figure 1): racemic 
 
 
 
 
 
 
 
3o (Figure 1): enantioenriched, 97% ee 
 
 
 
 
  
TMS
Me
TMS
Me
   
 
S77 
7a (Figure 2): racemic 
 
 
 
 
 
 
 
7a (Figure 2): enantioenriched, 93% ee 
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7b (Figure 2): racemic 
 
 
 
 
 
 
 
7b (Figure 2): enantioenriched, 88% ee 
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7c (Figure 2): racemic 
 
 
 
 
 
 
 
7c (Figure 2): enantioenriched, 90% ee 
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7d (Figure 2): racemic 
 
 
 
 
 
 
 
7d (Figure 2): enantioenriched, 92% ee 
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7e (Figure 2): racemic 
 
 
 
 
 
 
 
7e (Figure 2): enantioenriched, 94% ee 
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7f (Figure 2): racemic 
 
 
 
 
 
 
 
7f (Figure 2): enantioenriched, 82% ee 
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7g (Figure 2): racemic 
 
 
 
 
 
 
 
7g (Figure 2): enantioenriched, 97% ee 
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7h (Figure 2): racemic 
 
 
 
 
 
 
 
7h (Figure 2): enantioenriched, 95% ee 
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7i (Figure 2): racemic 
 
 
 
 
 
 
 
7i (Figure 2): enantioenriched, 97% ee 
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7j (Figure 2): racemic 
 
 
 
 
 
 
 
7j (Figure 2): enantioenriched, 98% ee 
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7k (Figure 2): racemic 
 
 
 
 
 
 
 
7k (Figure 2): enantioenriched, 96% ee 
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7l (Figure 2): racemic 
 
 
 
 
 
 
 
7l (Figure 2): enantioenriched, 93% ee 
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9 (Scheme 2): racemic 
 
 
 
 
 
 
 
9 (Scheme 2): enantioenriched, 91% ee 
 
 
 
 
 
 
 
  
TMS
OMe
TMS
OMe
   
 
S90 
9. X-ray Coordinate Tables for 4b 
 
Table S4. Atomic coordinates (x 10
4
) and equivalent isotropic displacement parameters (Å
2 
x 10
3
) for 4b.  
U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
Br(2) 7158(1) 11159(1) 5902(1) 23(1) 
Ni(1) 5957(1) 10344(1) 5110(1) 17(1) 
C(1) 7148(5) 7425(5) 5379(2) 17(1) 
N(1) 5905(5) 8301(5) 5263(2) 16(1) 
C(11) 3313(6) 7916(6) 5247(2) 20(1) 
O(1) 5007(5) 6190(5) 5481(2) 25(1) 
C(2) 6524(6) 5978(6) 5538(3) 20(1) 
C(10) 4805(6) 7514(6) 5330(2) 18(1) 
Br(1) 6632(1) 11327(1) 4262(1) 27(1) 
C(14) 3027(5) 9366(5) 5081(3) 17(1) 
O(2) 1668(5) 9629(5) 4965(2) 23(1) 
N(2) 3874(5) 10395(5) 5047(2) 17(1) 
C(16) 1592(6) 11077(6) 4742(3) 22(1) 
C(23) 2719(6) 12545(5) 5415(3) 19(1) 
C(9) 8035(5) 7124(6) 4876(2) 18(1) 
C(19) 748(7) 13449(6) 5936(3) 28(1) 
C(18) 1270(6) 12687(6) 5487(3) 23(1) 
C(8) 8818(6) 8080(6) 4570(3) 22(1) 
C(20) 1676(8) 14047(7) 6297(3) 27(1) 
C(15) 3037(6) 11685(6) 4910(3) 21(1) 
C(6) 9544(7) 6152(7) 3987(3) 25(1) 
C(12) 2328(7) 6732(6) 5060(4) 30(1) 
C(3) 7058(8) 4881(6) 5125(3) 28(1) 
C(7) 9565(6) 7606(7) 4124(3) 24(1) 
C(22) 3654(6) 13140(6) 5781(3) 24(1) 
C(4) 7974(6) 5693(6) 4733(3) 21(1) 
C(5) 8719(7) 5204(6) 4282(3) 23(1) 
C(17) 465(6) 11933(7) 5034(3) 27(1) 
C(13) 2195(7) 7222(7) 5622(3) 28(1) 
C(21) 3118(8) 13895(7) 6230(3) 28(1) 
______________________________________________________________________________
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Table S5. Bond lengths [Å] and angles [°] for 4b. 
_____________________________________________________  
Br(2)-Ni(1)  2.3747(10) 
Ni(1)-N(1)  1.973(5) 
Ni(1)-Br(1)  2.3583(10) 
Ni(1)-N(2)  1.981(5) 
C(1)-H(1)  1.0000 
C(1)-N(1)  1.471(7) 
C(1)-C(2)  1.544(8) 
C(1)-C(9)  1.516(8) 
N(1)-C(10)  1.293(7) 
C(11)-C(10)  1.479(8) 
C(11)-C(14)  1.459(7) 
C(11)-C(12)  1.530(8) 
C(11)-C(13)  1.549(9) 
O(1)-C(2)  1.459(7) 
O(1)-C(10)  1.323(7) 
C(2)-H(2)  1.0000 
C(2)-C(3)  1.534(9) 
C(14)-O(2)  1.344(7) 
C(14)-N(2)  1.266(7) 
O(2)-C(16)  1.479(7) 
N(2)-C(15)  1.496(7) 
C(16)-H(16)  1.0000 
C(16)-C(15)  1.542(9) 
C(16)-C(17)  1.521(9) 
C(23)-C(18)  1.391(8) 
C(23)-C(15)  1.509(9) 
C(23)-C(22)  1.380(9) 
C(9)-C(8)  1.389(9) 
C(9)-C(4)  1.402(8) 
C(19)-H(19)  0.9500 
C(19)-C(18)  1.404(9) 
C(19)-C(20)  1.369(11) 
C(18)-C(17)  1.522(10) 
C(8)-H(8)  0.9500 
C(8)-C(7)  1.374(9) 
C(20)-H(20)  0.9500 
C(20)-C(21)  1.384(10) 
C(15)-H(15)  1.0000 
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C(6)-H(6)  0.9500 
C(6)-C(7)  1.419(10) 
C(6)-C(5)  1.392(10) 
C(12)-H(12A)  0.9900 
C(12)-H(12B)  0.9900 
C(12)-C(13)  1.454(12) 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(3)-C(4)  1.504(9) 
C(7)-H(7)  0.9500 
C(22)-H(22)  0.9500 
C(22)-C(21)  1.405(9) 
C(4)-C(5)  1.388(9) 
C(5)-H(5)  0.9500 
C(17)-H(17A)  0.9900 
C(17)-H(17B)  0.9900 
C(13)-H(13A)  0.9900 
C(13)-H(13B)  0.9900 
C(21)-H(21)  0.9500 
 
N(1)-Ni(1)-Br(2) 100.22(14) 
N(1)-Ni(1)-Br(1) 124.10(14) 
N(1)-Ni(1)-N(2) 90.77(19) 
Br(1)-Ni(1)-Br(2) 117.13(4) 
N(2)-Ni(1)-Br(2) 122.24(15) 
N(2)-Ni(1)-Br(1) 101.14(14) 
N(1)-C(1)-H(1) 111.6 
N(1)-C(1)-C(2) 104.1(4) 
N(1)-C(1)-C(9) 113.2(5) 
C(2)-C(1)-H(1) 111.6 
C(9)-C(1)-H(1) 111.6 
C(9)-C(1)-C(2) 104.4(4) 
C(1)-N(1)-Ni(1) 124.8(4) 
C(10)-N(1)-Ni(1) 127.7(4) 
C(10)-N(1)-C(1) 107.2(5) 
C(10)-C(11)-C(12) 115.8(5) 
C(10)-C(11)-C(13) 117.7(5) 
C(14)-C(11)-C(10) 117.3(5) 
C(14)-C(11)-C(12) 119.7(5) 
C(14)-C(11)-C(13) 115.9(5) 
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C(12)-C(11)-C(13) 56.4(5) 
C(10)-O(1)-C(2) 107.5(4) 
C(1)-C(2)-H(2) 111.4 
O(1)-C(2)-C(1) 103.4(4) 
O(1)-C(2)-H(2) 111.4 
O(1)-C(2)-C(3) 110.9(5) 
C(3)-C(2)-C(1) 108.1(5) 
C(3)-C(2)-H(2) 111.4 
N(1)-C(10)-C(11) 127.2(5) 
N(1)-C(10)-O(1) 117.8(5) 
O(1)-C(10)-C(11) 114.9(5) 
O(2)-C(14)-C(11) 114.3(5) 
N(2)-C(14)-C(11) 128.8(5) 
N(2)-C(14)-O(2) 116.9(5) 
C(14)-O(2)-C(16) 107.2(4) 
C(14)-N(2)-Ni(1) 127.5(4) 
C(14)-N(2)-C(15) 107.9(4) 
C(15)-N(2)-Ni(1) 124.5(4) 
O(2)-C(16)-H(16) 112.0 
O(2)-C(16)-C(15) 101.9(4) 
O(2)-C(16)-C(17) 110.9(5) 
C(15)-C(16)-H(16) 112.0 
C(17)-C(16)-H(16) 112.0 
C(17)-C(16)-C(15) 107.5(5) 
C(18)-C(23)-C(15) 110.6(5) 
C(22)-C(23)-C(18) 120.9(6) 
C(22)-C(23)-C(15) 128.5(5) 
C(8)-C(9)-C(1) 127.5(5) 
C(8)-C(9)-C(4) 121.3(5) 
C(4)-C(9)-C(1) 111.1(5) 
C(18)-C(19)-H(19) 120.4 
C(20)-C(19)-H(19) 120.4 
C(20)-C(19)-C(18) 119.3(6) 
C(23)-C(18)-C(19) 119.8(6) 
C(23)-C(18)-C(17) 111.0(5) 
C(19)-C(18)-C(17) 129.2(6) 
C(9)-C(8)-H(8) 120.4 
C(7)-C(8)-C(9) 119.2(6) 
C(7)-C(8)-H(8) 120.4 
C(19)-C(20)-H(20) 119.4 
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C(19)-C(20)-C(21) 121.1(6) 
C(21)-C(20)-H(20) 119.4 
N(2)-C(15)-C(16) 103.0(5) 
N(2)-C(15)-C(23) 111.4(5) 
N(2)-C(15)-H(15) 112.6 
C(16)-C(15)-H(15) 112.6 
C(23)-C(15)-C(16) 104.0(5) 
C(23)-C(15)-H(15) 112.6 
C(7)-C(6)-H(6) 119.6 
C(5)-C(6)-H(6) 119.6 
C(5)-C(6)-C(7) 120.9(6) 
C(11)-C(12)-H(12A) 117.5 
C(11)-C(12)-H(12B) 117.5 
H(12A)-C(12)-H(12B) 114.6 
C(13)-C(12)-C(11) 62.5(4) 
C(13)-C(12)-H(12A) 117.5 
C(13)-C(12)-H(12B) 117.5 
C(2)-C(3)-H(3A) 110.7 
C(2)-C(3)-H(3B) 110.7 
H(3A)-C(3)-H(3B) 108.8 
C(4)-C(3)-C(2) 105.2(5) 
C(4)-C(3)-H(3A) 110.7 
C(4)-C(3)-H(3B) 110.7 
C(8)-C(7)-C(6) 119.8(6) 
C(8)-C(7)-H(7) 120.1 
C(6)-C(7)-H(7) 120.1 
C(23)-C(22)-H(22) 120.6 
C(23)-C(22)-C(21) 118.8(6) 
C(21)-C(22)-H(22) 120.6 
C(9)-C(4)-C(3) 111.2(5) 
C(5)-C(4)-C(9) 120.0(6) 
C(5)-C(4)-C(3) 128.9(5) 
C(6)-C(5)-H(5) 120.6 
C(4)-C(5)-C(6) 118.7(5) 
C(4)-C(5)-H(5) 120.6 
C(16)-C(17)-C(18) 103.8(5) 
C(16)-C(17)-H(17A) 111.0 
C(16)-C(17)-H(17B) 111.0 
C(18)-C(17)-H(17A) 111.0 
C(18)-C(17)-H(17B) 111.0 
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H(17A)-C(17)-H(17B) 109.0 
C(11)-C(13)-H(13A) 117.7 
C(11)-C(13)-H(13B) 117.7 
C(12)-C(13)-C(11) 61.2(4) 
C(12)-C(13)-H(13A) 117.7 
C(12)-C(13)-H(13B) 117.7 
H(13A)-C(13)-H(13B) 114.8 
C(20)-C(21)-C(22) 120.1(7) 
C(20)-C(21)-H(21) 119.9 
C(22)-C(21)-H(21) 119.9 
_____________________________________________________________  
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Table S6. Anisotropic displacement parameters (Å
2
x 10
3
) for 4b. The anisotropic displacement factor 
exponent takes the form: -2p
2 
[h
2
 a*
2 
U
11
 + ...  + 2 h k a* b* U
12
] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
Br(2) 20(1)  21(1) 28(1)  1(1) -3(1)  -5(1) 
Ni(1) 11(1)  14(1) 25(1)  3(1) 0(1)  -2(1) 
C(1) 12(2)  14(2) 26(2)  -1(2) -2(2)  4(2) 
N(1) 12(2)  16(2) 20(2)  0(1) 0(1)  2(1) 
C(11) 14(2)  13(2) 32(3)  0(2) -2(2)  4(2) 
O(1) 15(2)  12(2) 48(3)  1(2) -1(2)  2(1) 
C(2) 19(2)  12(2) 30(3)  4(2) -1(2)  5(2) 
C(10) 17(2)  15(2) 23(2)  1(2) -1(2)  2(2) 
Br(1) 24(1)  31(1) 25(1)  8(1) 4(1)  -1(1) 
C(14) 10(2)  16(2) 26(2)  1(2) -2(2)  3(1) 
O(2) 13(2)  18(2) 38(2)  4(2) -3(2)  3(1) 
N(2) 11(2)  18(2) 22(2)  2(2) 2(1)  5(1) 
C(16) 16(2)  17(2) 32(3)  6(2) -1(2)  6(2) 
C(23) 17(2)  9(2) 32(3)  5(2) 5(2)  2(2) 
C(9) 8(2)  17(2) 27(2)  -3(2) -3(2)  2(2) 
C(19) 24(2)  18(2) 41(3)  4(2) 10(2)  -6(2) 
C(18) 19(2)  15(2) 34(3)  4(2) 5(2)  2(2) 
C(8) 15(2)  20(2) 31(3)  -4(2) 2(2)  2(2) 
C(20) 30(3)  18(2) 34(3)  1(2) 12(2)  5(2) 
C(15) 15(2)  18(2) 28(2)  6(2) 2(2)  9(2) 
C(6) 20(2)  27(3) 28(3)  -2(2) -2(2)  11(2) 
C(12) 15(2)  13(2) 61(4)  -3(2) -7(2)  -4(2) 
C(3) 35(3)  12(2) 37(3)  2(2) 7(3)  0(2) 
C(7) 15(2)  27(3) 30(3)  1(2) 2(2)  5(2) 
C(22) 18(2)  13(2) 40(3)  5(2) 3(2)  1(2) 
C(4) 20(2)  14(2) 27(2)  1(2) -2(2)  3(2) 
C(5) 24(2)  18(2) 27(2)  -4(2) -2(2)  6(2) 
C(17) 15(2)  20(2) 48(4)  2(2) -3(2)  2(2) 
C(13) 15(2)  22(3) 48(4)  9(2) 3(2)  -7(2) 
C(21) 34(3)  19(2) 31(3)  -1(2) 4(2)  5(2) 
______________________________________________________________________________ 
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Table S7. Hydrogen coordinates (x 10
4
) and isotropic displacement parameters (Å
2
 x 10
3
) for 4b. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(1) 7730 7830 5682 21 
H(2) 6782 5713 5921 24 
H(16) 1459 11081 4335 26 
H(19) -240 13548 5989 33 
H(8) 8837 9049 4668 26 
H(20) 1326 14574 6598 33 
H(15) 3481 12258 4612 25 
H(6) 10100 5821 3690 30 
H(12A) 1564 6980 4802 36 
H(12B) 2748 5788 5001 36 
H(3A) 7610 4137 5312 34 
H(3B) 6260 4435 4929 34 
H(7) 10095 8250 3909 29 
H(22) 4642 13041 5730 29 
H(5) 8665 4242 4176 28 
H(17A) -274 11311 5189 33 
H(17B) 18 12618 4782 33 
H(13A) 2536 6591 5917 34 
H(13B) 1351 7785 5718 34 
H(21) 3746 14303 6488 33 
________________________________________________________________________________ 
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Table S8. Torsion angles [°] for 4b. 
________________________________________________________________  
Ni(1)-N(1)-C(10)-C(11) 7.4(9) 
Ni(1)-N(1)-C(10)-O(1) -173.6(4) 
Ni(1)-N(2)-C(15)-C(16) 163.3(4) 
Ni(1)-N(2)-C(15)-C(23) -85.7(5) 
C(1)-N(1)-C(10)-C(11) -178.4(6) 
C(1)-N(1)-C(10)-O(1) 0.6(7) 
C(1)-C(2)-C(3)-C(4) -0.2(7) 
C(1)-C(9)-C(8)-C(7) 179.7(5) 
C(1)-C(9)-C(4)-C(3) -0.5(7) 
C(1)-C(9)-C(4)-C(5) 180.0(5) 
N(1)-C(1)-C(2)-O(1) 1.2(6) 
N(1)-C(1)-C(2)-C(3) 118.9(5) 
N(1)-C(1)-C(9)-C(8) 67.1(7) 
N(1)-C(1)-C(9)-C(4) -112.2(5) 
C(11)-C(14)-O(2)-C(16) -173.2(5) 
C(11)-C(14)-N(2)-Ni(1) 9.2(10) 
C(11)-C(14)-N(2)-C(15) -174.7(6) 
O(1)-C(2)-C(3)-C(4) 112.5(6) 
C(2)-C(1)-N(1)-Ni(1) 173.3(4) 
C(2)-C(1)-N(1)-C(10) -1.1(6) 
C(2)-C(1)-C(9)-C(8) 179.6(6) 
C(2)-C(1)-C(9)-C(4) 0.3(6) 
C(2)-O(1)-C(10)-N(1) 0.3(8) 
C(2)-O(1)-C(10)-C(11) 179.4(5) 
C(2)-C(3)-C(4)-C(9) 0.4(7) 
C(2)-C(3)-C(4)-C(5) 179.9(6) 
C(10)-C(11)-C(14)-O(2) 174.3(5) 
C(10)-C(11)-C(14)-N(2) -7.7(10) 
C(10)-C(11)-C(12)-C(13) 107.3(6) 
C(10)-C(11)-C(13)-C(12) -104.0(6) 
C(10)-O(1)-C(2)-C(1) -1.0(6) 
C(10)-O(1)-C(2)-C(3) -116.6(5) 
C(14)-C(11)-C(10)-N(1) -1.3(9) 
C(14)-C(11)-C(10)-O(1) 179.8(5) 
C(14)-C(11)-C(12)-C(13) -103.0(7) 
C(14)-C(11)-C(13)-C(12) 109.8(6) 
C(14)-O(2)-C(16)-C(15) -15.5(6) 
C(14)-O(2)-C(16)-C(17) -129.6(6) 
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C(14)-N(2)-C(15)-C(16) -12.9(7) 
C(14)-N(2)-C(15)-C(23) 98.1(6) 
O(2)-C(14)-N(2)-Ni(1) -172.8(4) 
O(2)-C(14)-N(2)-C(15) 3.3(8) 
O(2)-C(16)-C(15)-N(2) 16.6(6) 
O(2)-C(16)-C(15)-C(23) -99.8(5) 
O(2)-C(16)-C(17)-C(18) 93.8(6) 
N(2)-C(14)-O(2)-C(16) 8.5(8) 
C(23)-C(18)-C(17)-C(16) 10.7(7) 
C(23)-C(22)-C(21)-C(20) -0.7(9) 
C(9)-C(1)-N(1)-Ni(1) -74.0(5) 
C(9)-C(1)-N(1)-C(10) 111.7(5) 
C(9)-C(1)-C(2)-O(1) -117.7(5) 
C(9)-C(1)-C(2)-C(3) -0.1(6) 
C(9)-C(8)-C(7)-C(6) -0.9(9) 
C(9)-C(4)-C(5)-C(6) 1.6(9) 
C(19)-C(18)-C(17)-C(16) -169.1(6) 
C(19)-C(20)-C(21)-C(22) 1.1(10) 
C(18)-C(23)-C(15)-N(2) -120.8(5) 
C(18)-C(23)-C(15)-C(16) -10.4(6) 
C(18)-C(23)-C(22)-C(21) 0.0(9) 
C(18)-C(19)-C(20)-C(21) -0.9(10) 
C(8)-C(9)-C(4)-C(3) -179.8(6) 
C(8)-C(9)-C(4)-C(5) 0.6(9) 
C(20)-C(19)-C(18)-C(23) 0.2(9) 
C(20)-C(19)-C(18)-C(17) 180.0(6) 
C(15)-C(16)-C(17)-C(18) -16.8(6) 
C(15)-C(23)-C(18)-C(19) 179.7(5) 
C(15)-C(23)-C(18)-C(17) -0.1(7) 
C(15)-C(23)-C(22)-C(21) -179.4(6) 
C(12)-C(11)-C(10)-N(1) 149.2(7) 
C(12)-C(11)-C(10)-O(1) -29.8(8) 
C(12)-C(11)-C(14)-O(2) 25.0(9) 
C(12)-C(11)-C(14)-N(2) -156.9(7) 
C(3)-C(4)-C(5)-C(6) -177.8(6) 
C(7)-C(6)-C(5)-C(4) -3.6(9) 
C(22)-C(23)-C(18)-C(19) 0.2(8) 
C(22)-C(23)-C(18)-C(17) -179.6(5) 
C(22)-C(23)-C(15)-N(2) 58.7(8) 
C(22)-C(23)-C(15)-C(16) 169.0(5) 
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C(4)-C(9)-C(8)-C(7) -1.0(9) 
C(5)-C(6)-C(7)-C(8) 3.2(9) 
C(17)-C(16)-C(15)-N(2) 133.2(5) 
C(17)-C(16)-C(15)-C(23) 16.9(6) 
C(13)-C(11)-C(10)-N(1) -147.0(6) 
C(13)-C(11)-C(10)-O(1) 34.0(8) 
C(13)-C(11)-C(14)-O(2) -39.4(8) 
C(13)-C(11)-C(14)-N(2) 138.6(7) 
________________________________________________________________  
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